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Abstract 
In recent years, the mechanisms of post-transcriptional regulation of gene 
expression have gained increased attention, including their importance in oligomeric 
protein assembly. The ER based proteins CAML and WRB have been described to form 
a heteromeric protein complex that functions as a receptor for the TRC40 ATPase, 
mediating the post-translational insertion of tail-anchored proteins into the ER 
membrane. A recent study showed that, even if the two proteins are not in a 
stoichiometric equilibrium - CAML is in ~5-fold excess over WRB -, the transient siRNA 
mediated depletion of each one of the two subunits, in HeLa cells, leads to the depletion 
of the second one. Interestingly, the silencing of CAML leads not only to the depletion of 
WRB protein but also to the depletion and strong destabilization of WRB mRNA, 
revealing a novel mechanism for the regulation of the expression of different subunits of 
a protein complex. In this thesis, I have followed up on this work, trying to unveil the 
mechanisms involved in the co-regulation of the expression and assembly of the TRC40 
receptor complex. My results demonstrate that the interplay observed at the transcript 
level is not reciprocal, i.e. CAML mRNA is not affected by WRB siRNA mediated 
depletion, and that the CAML-sensitivity of the WRB transcript is attributable to a 
relatively small portion (370 nt) of its 3' untranslated sequence (UTR), as shown by the 
results obtained with the dual-luciferase reporter system. Moreover, co-IP experiments 
show that CAML is indeed in excess over WRB and that a WRB-free population of CAML 
exists. It remains however unclear, what mechanism may explain the depletion of CAML 
upon WRB silencing. Finally, I propose a model according to which, on the one hand, 
CAML protein either directly or indirectly interacts with the 3’UTR of WRB, promoting 
is stability, which is lost when CAML is silenced. On the other hand, CAML may be 
inserted in the ER membrane in an unusual way, via the TRC40 pathway, meaning that it 
would require a functional TRC40 receptor complex, which is lost when WRB is silenced. 
The resulting non-inserted CAML molecules would then be degraded by the ubiquitin-
proteasome system. Future work is required to further understand the precise 
mechanisms involved in the co-regulation of the expression of the two subunits of the 
TRC40 receptor. This work could pave the way for the discovery of new post-
transcriptional co-regulatory mechanisms for the expression and assembly of oligomeric 
protein subunits, which could very well be relevant to many different protein complexes. 
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Riassunto 
Durante gli ultimi anni, un'attenzione crescente è stata rivolta ai meccanismi della 
regolazione dell'espressione genica post-trascrizionale, meccanismi che rivestono 
particolare importanza nell'assemblaggio di proteine oligomeriche. Le proteine del 
reticolo endoplasmatico, CAML e WRB, formano un complesso eteromerico che 
funziona come recettore dell'ATPasi TRC40, mediando così l'inserimento nella 
membrana dell'ER delle proteine "tail-anchored" (cioè con àncora transmembrana C-
terminale). Uno studio recente ha dimostrato che anche se queste due proteine non sono 
in equilibrio stechiometrico - poiché CAML è in eccesso molare di 5 volte rispetto a WRB 
-, il silenziamento transiente tramite siRNA di ciascuna delle subunità, in cellule HeLa, 
causa la deplezione della seconda. Un'osservazione molto interessante di questo studio è 
stata che il silenziamento di CAML non solo porta alla deplezione della proteina WRB 
ma anche alla destabilizzazione del corrispondente mRNA, rivelando così un nuovo 
meccanismo per la regolazione dell'espressione delle subunità di un complesso proteico. 
In questa tesi sono partito da questa osservazione con lo scopo di svelare i meccanismi 
coinvolti nella co-regolazione dell'espressione e assemblaggio del complesso recettoriale 
per TRC40. I risultati ottenuti dimostrano che l'effetto del silenziamento di ciascuna delle 
subunità sull'mRNA dell'altra non è reciproco, poiché i livelli dell'mRNA di CAML non 
sono modificati in seguito a deplezione di WRB. Ho dimostrato inoltre che la sensibilità 
del trascritto WRB alla mancanza di CAML è attribuibile a una porzione ristretta (370 nt) 
della regione 3' non tradotta (3'UTR), come dimostrato da esperimenti usando il sistema 
reporter della luciferasi. Inoltre, esperimenti di co-IP hanno confermato l'eccesso molare 
di CAML rispetto a WRB e dimostrato che nel reticolo esiste una popolazione di molecole 
CAML non associate a WRB, lasciando quindi aperto il meccanismo tramite cui WRB, in 
proporzioni sub-stechiometriche, garantisce la stabilità di CAML. Propongo un modello 
secondo il quale, da una parte, la proteina CAML interagisce, direttamente o 
indirettamente, con il 3'UTR del trascritto WRB stabilizzandolo; dall'altra CAML è 
inserito in membrana tramite il recettore TRC40, che viene a mancare quando WRB è 
silenziato. Le molecole di CAML non inserite verrebbero poi eliminate dal sistema 
ubiquitina-proteasoma. Ulteriori studi sono richiesti per la comprensione precisa dei 
meccanismi coinvolti nella co-regolazione dell'espressione delle due subunità del 
recettore TRC40.  Tali studi potrebbero aprire vie per la scoperta di nuovi meccanismi 
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post-trascrizionali regolatori dell'espressione e assemblaggio di oligomeri che potrebbero 
essere di rilevanza per altri complessi proteici. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 8	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 9	
List of abbreviations 
 
ARE – AU-rich element 
ARE-BP – AU-rich element binding protein 
CAML – Calcium modulating ligand 
CDH5 – Congenital heart disease 5 protein 
cDNA – Complementary DNA 
Co-IP – Co-immunoprecipitation 
Ct – Threshold cycle 
Cyt b5 – Cytochrome b5 
DB – Denaturation buffer 
DBC – Deoxy big chaps 
DMEM – Dulbecco’s modified eagle medium 
dNTP – deoxynucleotide triphosphate 
DRB – 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole  
DS – Down syndrome 
EGFR – Epidermal growth factor receptor 
eIF – Eukaryotic initiation factor 
EJC – Exon junction complex 
ER – Endoplasmic reticulum 
ERAD – ER-associated degradation 
FBS – Fetal bovine serum 
FRET – Fluorescence resonance energy transfer 
GET – Golgi to ER traffic 
hERG – Human ether-à-go-go-related gene 
Hsa1 – Distal region of the long arm of chromosome 21 
IP – Immunoprecipitation 
IRES – Internal ribosomal entry site 
KH – K-homology 
MOM – Mitocondrial outer membrane 
mRNA – Messenger RNA 
mRNP – messenger ribonucleoprotein particle 
NMD – Nonsense-mediated mRNA decay 
	 10	
ORF – Open reading frame 
PABP – Poly(A) binding protein 
PAGE – Polyacrylamide gel electrophoresis 
P-Body – Processing body 
PBS – Phosphate-buffered saline 
PCR – Polymerase chain reaction 
PDI – Protein disulphide isomerase 
PIC – Protease inhibitor cocktail 
PNS – Post nuclear supernatant 
Pre-mRNA – Precursor mRNA 
P/S – Penicillin/streptomycin antibiotic mix 
PTP1B – Protein tyrosine phosphatase 1B 
qPCR – quantitative PCR 
RACE – Rapid amplification of cDNA ends 
RBP – RNA-binding protein 
RISC – microRNA-induced silencing complex 
RRM – RNA-recognition motifs 
RT-qPCR – Reverse transcription quantitative PCR 
SDS – Sodium dodecyl sulfate 
Sgt2 – Small Glu-rich tetratricopeptide repeat-containing 2 
siRNA – small interfering RNA 
SND – SRP-independent pathway 
SRP – Signal recognition particle 
TA protein – Tail-anchored protein 
TAE – Tris-acetate buffer 
TCR – T-cell receptor 
TMD – Transmembrane domain 
TRC40 – 40 kDa subunit  of the transmembrane domain recognition complex 
uORF – upstream ORF 
UPS – Ubiquitin proteasome system 
UTR – Untranslated region 
WRB – Tryptophan rich protein 
	 11	
 
 
 
 
1 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
	 12	
1.1 Protein complexes 
  
Proteins are one of the building blocks of life. The genetic information contained 
in the DNA is transcribed into RNA that is then translated into protein in a flow of 
information that Crick defined as the Central Dogma of Biology. 
During translation, the ribosome reads the information contained in the 
messenger RNA (mRNA), encrypted in the four-letter genetic code, and translates each 
triplet - codon - into the corresponding amino acid, catalysing the formation of a chain 
of chemically bound amino acid residues that precisely represents the sequence carried 
by the mRNA. 
The resulting polypeptide chain represents the primary structure of a protein. The 
intrinsic properties of the amino acids that compose a polypeptide chain confer to them 
well defined physico-chemical characteristics that play a major role in the final protein 
structure. The process of folding the polypeptide chain into the mature protein begins 
with the local interaction of the different amino acids in the sequence that, by forming 
hydrogen bonds between them define the secondary structure of the protein. The most 
common secondary structures formed are a-helixes and b-sheets. Various combinations 
of secondary structures can be present in a polypeptide chain, forming protein domains. 
The formation of the tertiary structure of a protein, the overall three-dimensional 
form of the protein, is mostly driven by the forces exerted by the contact of the different 
amino acids with the surrounding medium. The different amino acids present different 
levels of hydrophobicity under physiological conditions, some amino acids are very 
hydrophobic while others are hydrophilic. Thus, the polypeptide chain tends to turn and 
twist to accommodate hydrophobic amino acids in the interior of the protein, while the 
hydrophilic amino acids remain exposed in the exterior, shielding the interior from the 
aqueous medium. This way, the protein will find itself in its lowest-energy state and 
therefore in its most stable state. To provide strength to this conformation, and higher 
stability, often disulphide bridges between cysteine residues, additional hydrogen bonds 
or other interaction are created in this step. 
In many cases, proteins are composed of multiple polypeptide chains, referred to 
as protein subunits. These subunits can be identical (homomers) or different 
(heteromers). In these cases, two or more polypeptides form a larger aggregate protein 
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complex by interacting with each other and often rearranging themselves to obtain a 
higher stability. 
Throughout the maturation process the proteins are subjected to various forms of 
modification, called post-translational modifications, that serve to either increase or 
decrease their stability. 
The folding and maturation of a protein or a protein complex into its final, native 
state, where it is in its most stable natural conformation is thus regulated at multiple levels, 
always driven by a common denominator, stability. When incompletely folded proteins 
find each other, it is highly probable that their hydrophobic regions will interact, creating 
aggregates of unfolded proteins. The tight regulation of folding and assembly is extremely 
important, since the presence of aggregated unfolded proteins can be detrimental for 
cellular homeostasis. Thus, when a protein for some reason loses its functional 
conformation, it is soon targeted for degradation, since the accumulation of unstable 
proteins could ultimately lead to cell death (Alberts et al. 2014; Nelson et al. 2012). 
 
1.1.1 Pharmacological receptors 
  
A receptor is a macromolecule, often a protein or a complex of proteins, that 
interacts with chemical substances such as hormones, neurotransmitters, intracellular 
messengers or drugs, transmitting chemical signals inside and between cells. This signal 
transmission triggers a response in the form of a change in cellular function. 
Most drugs act by targeting cellular receptors, changing their function or activity 
dynamics, either as agonists or antagonists. These receptors can be divided in two main 
families: membrane receptors and intracellular receptors.  
Some examples of intracellular receptors are the receptors for steroids, thyroid 
hormone, vitamin A and D, oestrogen and retinoic acid. These are generally formed by 
monomeric proteins composed of three main domains: (i) a C-terminal ligand binding 
site; (ii) a central DNA binding domain, specific for a particular DNA sequence; and (iii) 
a N-terminal regulatory domain responsible for gene transactivation. 
The wider family of membrane receptors, on the other hand, can be further 
divided into three major subgroups: ligand-gated ion channels, G protein-coupled 
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receptors and enzyme-linked receptors. The latter classes are most commonly 
monomeric proteins, while the first are oligomeric proteins, which I describe here. 
Ligand-gated ion channels are membrane-embedded oligomeric protein 
complexes that upon ligand binding, undergo a transitory conformational change that 
opens a channel through the membrane, through which ions flow, causing a variation in 
the membrane electric potential. These protein complexes, that can be either homo or 
heteromeric, are composed of three, four or five subunits. Depending on the ions that 
permeate these receptors, they can induce a ligand mediated depolarization or 
hyperpolarization of the membrane, which is then important for several cellular functions 
and responses. Examples of this class of receptors are nicotinic, glutamate, serotonin, 
nucleotide, GABA, and glycine receptors. The intrinsic multimeric nature of this type of 
receptors, makes the assembly process of the complex a key step towards their proper 
function. Thus, one important aspect of the biology, of oligomeric ligand-gated ion 
channels, is the regulation of the assembly of the receptor complex: how the expression 
of each subunit is controlled and how the different subunits interact with each other to 
create a final, functional complex (Paoletti et al. 2004; Golan et al. 2006).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
	 15	
1.2 Regulation of protein complex folding and assembly 
  
1.2.1 Mechanisms of assembly 
 
The intracellular environment is a crowed place or, to be more precise, presents a 
strong exclusion volume effect. This effect is defined by the fact that each individual 
molecule occupies a certain space that, obviously, cannot be occupied by another 
molecule, thus that volume is unavailable for other molecules and is then said to be 
excluded from the total volume. Typically, macromolecules occupy approximately 20-30 
% of the intracellular milieu that is further occupied by diverse small molecules and 
solvents. This crowding effect is tightly related to the size of the molecule in question, so 
it is easy to imagine that entities such as proteins will be strongly affected by it (Ellis 2001). 
Crowding is thus a very important factor when talking about the regulation of 
protein folding, assembly and function. This has been extensively studied regarding the 
problem of protein folding. If earlier studies showed that small globular proteins could be 
denatured and re-folded back to the native state in vitro, in the absence of any other 
adjuvant (Anfinsen et al. 1961), later studies started to demonstrate that this may not be 
the case for more complex polypeptides. In fact, it has been shown that, some proteins 
assemble in vitro very inefficiently, but that the addition of crowding agents greatly 
increases the ability of the polypeptide to fold into the native conformation in-vitro by 
favouring the most compact state (Galán et al. 2001). However, the effects of crowding 
are not always positive. It has been demonstrated that the proper refolding of reduced 
lysozyme was abolished due to aggregation when in the presence of crowding agents. Yet, 
that aggregation was avoided when protein disulphide isomerase (PDI) was added to the 
reaction, this due both to PDI’s activity as disulphide bond catalyst and as molecular 
chaperone. Furthermore, it was shown that under crowding conditions, PDI was a much 
more effective molecular chaperone than that under dilute conditions (Van Den Berg et 
al. 1999).  
These are but examples of a large body of work, developed over the years, that 
showed that the essential information for the folding of the polypeptide chain into the 
native, most stable conformation, is embedded in the polypeptide sequence itself and that 
in some cases proteins can spontaneously fold by themselves in vitro. However, the highly 
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crowded intracellular environment in which polypeptides are synthesised often poses a 
barrier for the efficient folding of the proteins. In fact, crowding should favour 
aggregation by increasing the thermodynamic activity of partly folded polypeptides. This 
effect is on the one hand, greater for smaller polypeptides, since large ones have a reduced 
rate of diffusion and consequently of encounter with other macromolecules, and on the 
other hand, enhances the aggregation of slow-folding chains, as fast-folding chains can 
internalize their hydrophobic surfaces before these can bind to those in other chains (Ellis 
2001). Thus, the ability to fold, imprinted in the polypeptide sequence is not the sole 
parameter determining proper folding. The rate at which the folding happens is also 
important and determines the probability that a given polypeptide will interact with 
another one, before being completely folded, controlling in this way the formation of non-
specific aggregates. So, to overcome these issues, evolution found its solution in the use 
of molecular chaperones that aid the polypeptide in its folding process, while preventing 
non-intended interactions with other proteins that could lead to aggregation. The 
different levels of folding assistance start already co-translationally, while the ribosome is 
synthesising the polypeptide; indeed, there is even evidence that folding begins inside the 
ribosomal exit tunnel (Nilsson et al. 2015). 
The intricate processes that govern polypeptide folding are very well studied and 
progress is being made towards the prediction of the final native conformation of a 
protein, with a fairly good level of accuracy, by analysing the polypeptide sequence. Even 
more complex is the process of assembly of protein complexes composed of multiple 
subunits. It is well accepted though, that some of the forces that drive protein folding may 
also be important for protein complex assembly. This assembly is likely driven by the need 
of a subunit to find the right binding partner in order to shift towards a lower energetic 
state, this, while avoiding casual transient interactions that may lead to protein 
aggregation, and all this in the previously described crowded intracellular environment. 
Thus, if protein folding is very likely to be a process for which regulation starts 
immediately after translation, to reduce the risk of misfolding and aggregation, and to 
lower the overall energy needed for the process, the same is probably true for the assembly 
of multimeric protein complexes (Natan et al. 2017). 
Indeed, considering the expected low diffusion rate of large complex subunits in 
crowded conditions, it is natural to predict that assembly could, at least in certain cases, 
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happen co-translationally (Siwiak and Zielenkiewicz 2015). The co-translational 
assembly of homomeric complexes can be idealized in manner more straight forward 
than that of heteromers. Homomers, as detailed above, are composed of a single subunit 
type, thus they can be formed by polypeptides being translated in the same polyribosome 
(Fig. 1.1-A). In this way, the nascent peptides of two monomers could begin interacting 
and assembling before either one of the subunits is fully translated. Another view is that 
a fully translated subunit can interact with the nascent chain of a second subunit initiating 
the co-translational assembly (Natan et al. 2017; Wells et al. 2015). The first proposed case 
of co-translational homomer assembly was that of b-Galactosidase in the 60’s (Kiho and 
Rich 1964). 
The assembly of heteromers, can be more complex. In prokaryotes, the hypothesis 
of co-translational assembly of heteromers can be interpreted in the same way as 
described above for homomers, since it is widely accepted that the operon architecture of 
prokaryotic genes generally puts together in a polycistronic messenger RNA proteins that 
physically interact (Dandekarab et al. 1998; Shieh et al. 2015). Thus, each subunit is 
translated in the same operon in a sequential manner and the co-translational assembly 
is facilitated by the proximity between the interacting subunits (Fig. 1.1-C) (Li et al. 2014). 
Co-translational assembly of heteromeric complexes in eukaryotes, however, 
presents an additional challenge. In eukaryotes, each gene is translated from a 
monocystronic mRNA, thus, co-translational assembly can happen in two major modes 
(Fig. 1.1-B): (i) a fully translated subunit may interact with the nascent chain of the second 
subunit, initiating the assembly while it is being translated, or (ii) two different 
polyribosomes, translating in proximity, allow for the interaction of the nascent chains of 
two subunits of a protein complex. In these cases, an extra level of regulation is present, 
the regulation of the spatio-temporal localization of mRNA, which is very important to 
allow for the interaction by proximity of the two newly formed polypeptides. In 
agreement, Duncan and Mata (2011) have shown that 40 % of a selected number of 
proteins, that did not have any canonical RNA binding domains, interacted with the 
mRNAs of binding partners in a translation dependent manner. Moreover, Morisaki and 
colleagues (Morisaki et al. 2016), using recently developed microscopy techniques that 
allow the visualization at single molecule resolution of real-time, live translation, 
observed the existence of a population of polysomes that were translating two different 
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transcripts in a complex that could be tracked over-time. Recently, a work by Liu and 
colleagues (Liu et al. 2016), demonstrated that the mRNA of the two subunits of an 
heteromeric K+ channel (hERG) are bound by a RNA binding protein that determines the 
proximity of the two transcripts, allowing the assembly of the complex co-translationally. 
The importance of the regulation of co-translational complex assembly for the stability 
and overall functionality of the resulting protein complex is thus becoming evident. 
 
 
 
 
 
Fig. 1.1 - Models for co-translational assembly of protein complexes. (A) Assembly of homomeric 
complexes. (B) Assembly of heteromeric complexes. (C) Assembly of prokaryote protein complexes by 
polycistronic mRNA. (Adapted from Natan et al. 2017) 
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1.2.2 Regulation of the production of receptor subunits in the correct 
stoichiometric ratios 
 
An important problem in the production of oligomeric complexes is to avoid the 
generation of an excess of one type of subunit over its partners. Indeed, an unassembled 
subunit, by exposing hydrophobic patches destined for interaction with partner subunits, 
could aggregate, with deleterious effects for the cell. As already mentioned, in prokaryotes 
this problem is solved by including the cistrons for oligomer subunits in the same operon., 
under the control of the same promoter. This arrangement leads to production of the 
subunits in stoichiometric ratio. Prokaryotes appear to exert a tight transcriptional 
control that guarantees the same levels of expression of genes encoding complex subunits 
even when these are not contained in the same operon, as demonstrated by a recent study 
of the group of Jonathan Weissman (Li et al. 2014). 
In eukaryotes, the transcriptional regulation of genes encoding subunits of the 
same complex has been less investigated. However, eukaryotic cells have a safeguard 
against unaccompanied complex subunits: these are recognised by the ubiquitin 
proteasome system (UPS), and degraded. Indeed, recently a mechanism responsible for 
the recognition of unassembled proteins was identified (Yanagitani et al. 2017). The 
instability of “lonely” subunits has become particularly visible since the introduction of 
silencing technology. There are countless examples in which knockdown of one oligomer 
subunit causes depletion of the other subunits of the complex (Peth et al. 2007; Colombo 
et al. 2016; Rivera-Monroy et al. 2016; Shrimal et al. 2017; to cite just a few). For receptors 
destined to the cell surface, this quality control system operates at the endoplasmic 
reticulum (ER), where newly synthesised subunits are born. Incompletely assembled 
oligomers and single subunits are not allowed to be exported to the Golgi apparatus and 
are instead retro-translocated to the cytoplasm, ubiquitinilated and degraded by the 
proteasome in a process known as ER-associated degradation (ERAD) (Bernasconi and 
Molinari 2011). 
In summary, to ensure efficient oligomer assembly, the eukaryotic cell controls 
gene transcription, maximizes assembly efficiency and disposes of any uncoupled 
subunits. There are, however, a number of steps in this general picture that remain to be 
	 20	
elucidated, as well as different behaviours and different modes of degradation of different 
oligomers. 
In my work, I have taken the case of a heteromeric receptor composed of two 
subunits, the TRC40 (40kDa subunit of the transmembrane domain recognition 
complex) receptor, for which previous work from my laboratory indicated a novel and 
intriguing mechanism of subunit co-regulation. My work could pave the way for the 
characterisation of a new mechanism regulating oligomeric complex expression and 
assembly that could operate also in pharmacologically relevant protein complexes. 
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1.3 TRC40 pathway for Tail-anchored protein insertion 
 
1.3.1 Tail-anchored (TA) membrane proteins 
    
It is estimated that about 30% of the genes of most genomes code for membrane 
proteins (Krogh et al. 2001), which, depending on number of transmembrane domains 
(TMD) and topological orientation can present a wide structural diversity. Most 
membrane proteins are assembled in the ER. In this cellular compartment, they are 
inserted into the membrane, fold and assemble into protein complexes. Apart from some 
exceptions, membrane proteins are inserted in the membrane co-translationally, via the 
signal recognition particle (SRP) pathway. During translation, when the first hydrophobic 
element, either a cleavable N-terminal sequence or a TMD, gets out of the ribosomal 
tunnel, it is recognized by the SRP that binds to the domain, causing a pause in 
translation. SRP then brings the entire translating unit to the ER by interacting with the 
SRP receptor. When in the ER, the SRP hands down the translating ribosome to the Sec61 
translocon, where the hydrophobic domain is introduced and translation is resumed. The 
translocon then mediates the lateral insertion of the TMDs in the membrane and 
translocation of exoplasmic domain(s) across the ER membrane (Shao and Hegde 2011) 
(see Fig 1.2).  
Fig. 1.2 - Representation of the SRP pathway. Adapted from Hegde and Keenan 2011 
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One well studied exception of this mechanism is the case of TA proteins. TA 
proteins are predicted to be distributed in all domains of life and they represent ~3-5% of 
all membrane proteins (Beilharz et al. 2003; Kalbfleisch et al. 2007; Borgese and Righi 
2010). This class of protein is characterized by having a single TMD no more than ~30 
residues from the C-terminus. This topology, combined with the lack of an N-terminal 
signal sequence, excludes TA proteins from the SRP pathway (Kutay, Hartmann, and 
Rapoport 1993; Borgese, Colombo, and Pedrazzini 2003). This is because, the TMD is so 
close to the C-terminus that it emerges from the ribosomal tunnel only upon termination 
and release of the translated polypeptide, thus the newly synthesized TA proteins must be 
inserted in the ER membrane post-translationally. Several TA proteins have been found 
to be players in several basic cellular processes, of which some examples are listed in Table 
1.1. 
 
Table 1.1 - Examples of TA protein targeting and function. (Adapted from Borgese and Fasana 2011) 
Target membrane TA protein Function 
ER Sec61β Protein translocation 
 Ramp4 Protein translocation 
 Synaptobrevin-2 SNARE required for synaptic vesicle exocytosis 
 Sed5 Golgi SNARE 
 Cyt b5 Lipid metabolism in the ER 
MOM Small TOM proteins Protein translocation 
 OMb5 Enzymatic 
 VAMP-1B SNARE 
 Bcl-XL, Bak Regulation of apoptosis 
Peroxisomes Pex26 Peroxisome biogenesis 
Dual targeting: ER and MOM Bcl-2 Regulation of apoptosis 
Dual targeting: MOM and 
peroxisomes Fis1 Mitochondrial and peroxisomal fission 
 
The mechanisms of post-translational translocation of TA proteins have been the 
focus of a great deal of work in the past decade. Depending on the physical properties of 
the TMD and on the target membrane organelle, TA proteins have been shown to be 
targeted and to insert into membranes through diverse mechanisms.  
TA proteins with low hydrophobic TMDs, like cytochrome b5 (cyt b5) and 
protein tyrosine phosphatase 1B (PTP1B), are able to insert into biological membranes 
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and even into pure phospholipid bilayers spontaneously, without the need for any 
additional machinery (Brambillasca et al. 2005, 2006; Colombo et al. 2009; Fueller et al. 
2015). The mechanism of the in-vivo targeting of these proteins is somewhat obscure, 
although it seems that lipid composition plays an important role (Brambillasca et al. 
2005). In addition, the group of Stephen High (Abell et al. 2007; Rabu et al. 2008) showed 
that, the chaperoning complex Hsp40/Hsc70 is able to mediate the ATP-dependent 
insertion of at least a subset of TA proteins containing moderately hydrophobic TMDs, 
like that of cyt b5, into the ER membrane. The precise mechanism by which this 
mediation takes place is still not completely understood since a membrane receptor for 
Hsp40/Hsc70 is still to be found. The current view is that this chaperone complex keeps 
TA proteins in an integration-competent form, preventing aggregation until the proteins 
reach the target membranes. 
A second pathway that has been reported for a subset of TA proteins with TMDs 
with a higher degree of hydrophobicity involves the participation of SRP in an unusual 
post-translational mode. It is thought that ribosome-associated SRP captures the 
substrate’s TMD immediately upon release from the ribosome (Abell et al. 2004). 
Most importantly, a 40 kDa AAA ATPase, called TMD recognition complex 
(TRC)40, (previously annotated Asna1) was shown to bind to TA proteins’ TMD and to 
be responsible for their targeting to the ER membrane (Stefanovic and Hegde 2007; 
Favaloro et al. 2008). These were the first of a series of studies that characterized the 
TRC40 pathway in mammals and the homologous GET system in yeast. This pathway is 
widely accepted to be the most important mechanism for the post-translational insertion 
of TA proteins in the ER membrane and will be further discussed in the following 
sections. 
Recently, a set of yeast proteins, called SND (SRP-independent pathway) protein, 
were shown to be able to mediate the ER targeting and translocation of ER substrates 
(Aviram et al. 2016). The authors demonstrate that the SND pathway works in parallel 
with both the SRP and GET pathways, contributing to the ER targeting of both secretory 
and TA proteins. 
An issue that remains to be completely understood is the targeting and insertion 
of TA proteins in other membrane organelles. For mitochondria, the most accepted 
hypothesis is that TA proteins are spontaneously inserted in the mitochondrial outer 
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membrane (MOM) (Kemper et al. 2008). It is however, unclear what is the mechanism 
by which those proteins are selectively targeted to the mitochondria. Recent results 
indicate that TA proteins with moderately hydrophobic TMDs may, by default, be 
spontaneously inserted in the MOM and may need some energy-dependent mechanism, 
other than those already discussed to be targeted to the ER instead (Costa et al. 2017 - 
manuscript submitted for publication). 
The peroxisome is another organelle that appears to have its own TA protein 
insertion machinery that may act in parallel with the traditional ER-trafficking route. In 
this organelle, PEX19 and PEX3 have been shown to be responsible for the insertion of 
several TA proteins as well as of other membrane proteins (Halbach et al. 2006; 
Mayerhofer 2016). 
TA proteins are, as already mentioned, quite abundant in the eukaryotic 
proteome. They are well distributed between all membrane systems of eukaryotic cells 
and there are examples of TA proteins having a role in almost every aspect of cell biology 
(see Table 1.1). Several TA proteins are linked to diverse pathologies, some examples of 
which are listed in Table 1.2. Thus, a detailed understanding of their biogenesis could 
provide insight into unknown roles played by TA proteins in other diseases, caused not 
only by mutations in the TA proteins themselves, but also by dysregulations of the cellular 
machinery involved in their targeting and insertion into membranes. Such knowledge 
could lead to the discovery of novel therapeutical targets. 
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TA protein Gene Pathology associated 
Aldehyde dehydrogenase 3A2 isoform 2 ALDH3A2 Sjogren-Larsson syndrome 
Apoptosis regulator Bcl2 BCL2 Chronic lymphatic leukaemia 
Cardiac phospholamban PLN Hypertrophic cardiomyopathy; Dilated cardiomyopathy 
Cytochrome b5 CYB5A Methemoglobinemia 
Dysferin DYSF Limb-girdle muscular dystrophy 2B; Miyoshi muscular dystrophy; 
Emerin EMD Dreifuss-Emery muscular dystrophy 
FXYD domain-containing ion transport 
regulator 2 isoform 1 FXYD2 Renal hypomagnesemia-2 
Golgi SNAP receptor complex member 2 GOSR2 Epilepsy, progressive myoclonic 6 
Golgin subfamily A member 5 GOLGA5 Papillary thyroid carcinomas 
Hereditary hemochromatosis protein HFE Hemochromatosis 1; Microvascular complications of diabetes 7 
Junctophilin-2 JPH2 Cardiomyopathy, familial hypertrophic 17 
Junctophilin-3 JPH3 Huntington disease-like 2 
Mitochondrial fission factor MFF Encephalopathy due to defective mitochondrial and peroxisomal fission 2 
Monoamine oxidase A MAOA Brunner syndrome 
Myotonin-protein kinase DMPK Dystrophia myotonica 1 
Otoferlin OTOF Deafness, autosomal recessive, 9; Auditory neuropathy, autosomal recessive, 1 
Potassium voltage-gated channel 
subfamily E member 3 KCNE3 Brugada syndrome 
Regulator of G-protein signaling 9-
binding protein RGS9BP 
Prolonged electroretinal response 
suppression 
Selectin L SELL Immunoglobulin A nephropathy 
Syntaxin-1B STX1B Generalized epilepsy with febrile seizures plus 9 
Sodium/potassium-transporting ATPase 
subunit gamma FXYD2 Hypomagnesemia 2 
Syntaxin 16 isoform a STX16 Pseudohypoparathyroidism type Ib 
Syntaxin 1A STX1A Williams-Beuren syndrome 
Tectonic-3 TCTN3 Orofaciodigital syndrome 4; Joubert syndrome 18 
Threonylcarbamoyladenosine tRNA 
methylthiotransferase CDKAL1 Diabetes mellitus, non-insulin-dependent 
Thymopoietin isoform beta/gamma TMPO Dilated cardiomyopathy 
VAMP-associated protein B/C VAPB Amyotrophic lateral scelerosis 8 
Vesicle-associated membrane protein 1 VAMP1 Spastic ataxia 1, autosomal dominant 
Table 1.2 - Examples of pathologies associated with TA proteins. (Source: Kalbfleisch, 2007; The 
UniProt Consortium 2017) 
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1.3.2 The GET system in yeast 
  
As stated before, Stefanovic and Hegde found TRC40 to bind and effectively 
delivery TA proteins to the ER membrane in an energy dependent way (Stefanovic and 
Hegde 2007), an observation that was reported independently by Favaloro et al. (2008).  
At this point, no other components of the TRC40 pathway were known, but its 
yeast homolog, Get3 had just been discovered, in a comprehensive genetic interaction 
study, to be part of a complex involved in Golgi to ER traffic (GET) together with Get1 
and Get2 (Schuldiner et al. 2005). Thus, it was not long until all three components of the 
yeast GET complex were shown to participate in the post-translational insertion of TA 
proteins. Get3, being the homolog for TRC40, is the chaperone with ATPase activity that 
binds to the TA protein TMD after translation and delivers it to the ER membrane, where 
Get1 and Get2 are the two subunits of a membrane receptor that binds Get3 and mediates 
the insertion of the TA proteins (Schuldiner et al. 2008). These discoveries led to the 
conclusion that the initial findings on the GET complex - its involvement in Golgi to ER 
trafficking and all otherwise unconnected phenotypes - were secondary effects caused by 
an impairment in TA protein insertion. Recent work, however, showed that things are 
not that simple and that in fact, some components of the GET system may have additional 
functions (Powis et al. 2013; Voth et al. 2014). 
Subsequently, Get4 and Get 5 (Jonikas et al. 2009) and Sgt2 (small Glu-rich 
tetratricopeptide repeat-containing 2) (Costanzo et al. 2010) were discovered as three 
additional members of the GET pathway. With the major players defined, the mechanism 
by which TA proteins are inserted in the ER membrane in yeast was elucidated using a 
combination of structural and functional studies. 
As schematized in Fig. 1.3, after translation, TA proteins are captured at the exit 
of the ribosomal tunnel by Sgt2 that binds directly to the TMD of TA proteins, acting as 
a chaperone that prevents TA protein aggregation or mistargeting, before handing them 
down to Get 3. For this hand-off to occur, Sgt2 binds the ubiquitin-like domain of Get5, 
to interact with the Get4-Get5 sub-complex, that serves as a bridge between Sgt2 and Get3 
(the latter binds to Get4) (Wang et al. 2010). Crucially, Get4 selectively binds the ATP-
bound (and thus TA TMD receptive) conformation of Get3 (Chartron et al. 2010), 
allowing the transfer of the TA protein from Sgt2 to Get3. 
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Get3 is a homodimeric ATPase that, when bound to ATP is in a closed 
conformation that allows for the binding of TA TMDs and when ATP is hydrolysed 
transits to an open conformation that releases the TA proteins. Upon transfer of TA 
protein substrate from Sgt2 to Get3, Get3 carries the TA proteins in the cytosol, shielding 
and maintaining the solubility of the hydrophobic TMD, inside a hydrophobic groove 
that spans both Get3 monomers, arriving at the membrane in a closed conformation 
(Mateja et al. 2009, 2015). 
Get3 then delivers the TA protein to its ER membrane receptor, formed by Get1 
and Get2. The two monomers are bound by their transmembrane domains in a 
heterodimeric or tetrameric complex (Zalisko et al. 2017) and interact with Get3 via the 
cytosolic domains in a stepwise manner (Mateja et al. 2009, 2015; Mariappan et al. 2011; 
Wang et al. 2011; Stefer et al. 2011; Rome et al. 2014). First, the flexible cytosolic domain 
of Get2 captures the Get3/TA complex, by binding to one of the subunits of Get3, 
bringing it close to Get1; in this process, the ATP bound to Get3 is hydrolysed shifting 
the conformation into a partially destabilized closed conformation. Get1 then binds to 
Get3, creating a transient complex in which Get3 is bound simultaneously by Get2 on one 
side and Get1 on the opposite side (Zalisko et al. 2017). This transient interaction drives 
the Get3/TA complex from the previous partially destabilized closed conformation into 
an open conformation that disrupts the hydrophobic TA protein binding site, releasing 
the protein. After release, the TMDs of Get1 and Get2 capture the TMD of the TA 
proteins and may subsequently facilitate the entry of the tail-anchor into the membrane, 
Fig. 1.3 - Representation of the GET system in yeast. Adapted from Hegde and Keenan 2011 
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acting as an insertase (Wang et al. 2014). Get3 is again bound by ATP, which interrupts 
its interaction with Get1 and is recycled back to the cytosol where again is available for 
interaction with the Get4/Get5 pre-targeting complex.  
  
1.3.3 The TRC40 pathway 
   
The advances in the understanding the molecular mechanisms of post-
translational TA protein insertion in yeast allowed for a parallel definition, mostly 
through homology, of the players and mechanisms that compose the TRC40 pathway in 
mammals.  
In mammals, the pre-targeting complex is composed of the Sgt2 homolog, SGTA, 
a complex homologous to Get4/Get5 (TRC35/UBL4A in mammals), but that has a third 
component, Bag6 that seems to act as scaffold for the interaction between TRC35 and 
UBL4A; indeed, unlike the yeast homologs, the latter two proteins are not able to directly 
interact (Chartron et al. 2012). This pre-targeting complex, is then responsible for the 
capture of TA proteins from the ribosome and for its delivery to the TRC40 homodimer. 
Moreover, the Bag6 complex has been seen to be involved in protein quality control, 
binding a wide range of hydrophobic substrates and mediating the degradation of 
mistargeted proteins (Hessa et al. 2011). 
As for the membrane components of the TRC40 pathway, first the tryptophan-
rich basic protein (WRB) was found to be the mammalian homologue of Get1 and to be 
part of the membrane receptor for TRC40 (Vilardi et al. 2011). Based on bioinformatic 
analysis, however, no mammalian homologue was found for Get2. Nonetheless, a physical 
interaction assay, using TRC40 as bait, allowed the identification of CAML (calcium 
modulating cyclophilin ligand) as both a TRC40 and WRB interactor (Yamamoto and 
Sakisaka 2012). The authors showed that CAML binds TRC40 through a long cytosolic 
N-terminal domain (much as the interaction between Get2 and Get3) and interacts with 
WRB through the TMDs (again, like the yeast Get1/Get2 complex). Subsequent studies, 
demonstrated that the CAML/WRB complex was able to restore TA protein insertion 
competence both in DGet1/Get2 yeast cells (Vilardi et al. 2014) and in reconstituted 
proteoliposomes (Colombo et al. 2016), confirming the functional homology between 
CAML and Get2. The exact mechanisms by which the WRB/CAML protein interacts with 
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TRC40 and mediates TA protein insertion and how similar these processes are to what is 
observed in yeast is still poorly understood. 
A recent study that tried to further characterize the WRB/CAML complex and its 
regulation (Colombo et al. 2016) will be discussed in more depth in a following section. 
 
1.3.3.1 CAML 
 
Before being found to be an essential component of the TRC40 pathway 
(Yamamoto and Sakisaka 2012), CAML had been the focus of much attention, being 
found to interact with numerous proteins. CAML is a ubiquitously expressed, ER-
resident membrane protein with three putative transmembrane domains located in its C-
terminal region and a long cytosolic N-terminal arm. 
First discovered in 1994 by Richard Bram (Bram and Crabtree 1994) in a screen 
for cyclophilin B-binding proteins, CAML was described as being a participant in the 
calcium-signal transduction pathway, acting downstream of the T-cell receptor (TCR) 
and upstream of calcineurin by causing an influx of calcium. This action was suggested 
to be modulated by CAML’s TMDs (Holloway and Bram 1996). 
CAML was also found to interact with a member of the tumour necrosis factor 
receptor superfamily, inducing activation of the calcium-dependent transcription factor 
NF-AT in Jurkat T cells (von Bulow and Bram 1997). 
It was later suggested that CAML associates directly with the kinase domain of the 
EGFR (epidermal growth factor receptor), indicating a potential role of CAML in 
receptor recycling during long-term proliferative responses to EGF (Tran et al. 2003). 
Also, GABAA receptors were seen to interact with CAML, more precisely, the g2 
subunit of the GABAA receptors. This interaction was proposed to be important for the 
functional expression and endocytic recycling of GABAA receptors (Yuan et al. 2008). 
These are only some examples of the interactions and cellular process in which 
CAML has been found to take part, implying the importance of CAML for cellular 
homeostasis. It is a highly-conserved protein among vertebrates and is ubiquitously 
expressed. Moreover, CAML total knockout is lethal for mice embryos while mouse 
embryonic stem cells from CAML-knockout embryos grow without problems (Tran et al. 
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2003). To be noted, no homologues have been identified in non-vertebrate metazoans or 
in plants. 
Presently, it is still uncertain if the many processes in which a role for CAML has 
been implied is but a side effect of CAML being a component of the TRC40 pathway or 
if, instead, CAML has other functions besides being a part of the TRC40 receptor. A recent 
work points to the latter as being the most plausible answer, revealing an essential role for 
CAML in supporting survival and mitotic progression in Myc-driven lymphomas, 
independent  of TA protein insertion function (Shing et al. 2017). It remains to be 
understood if CAML in complex with WRB or WRB-free CAML may be responsible for 
these various functions reported for CAML. 
 
1.3.3.2 WRB 
 
WRB, also known as CHD5 (congenital heart disease 5 protein), is expressed from 
a gene located on chromosome 21 in a region thought to be responsible for CHD in Down 
syndrome (DS) (Egeo et al. 1998). WRB is an ER membrane protein, ubiquitously 
expressed, that has three transmembrane domains and a coiled-coil, cytoplasmic domain 
between the first and second TMDs. Recently it was shown that DS fetal fibroblasts 
presented an increased expression of WRB protein (Colombo et al. 2016), however the 
link between the higher expression of WRB and CHD occurrence in DS patients remains 
unclear. 
Differently from CAML, WRB is conserved throughout the eukaryotic domain of 
life. Different animal models showed that a reduced expression or a complete knock down 
of WRB led to defects in cardiac development and morphology (Murata et al. 2009; Sojka 
et al. 2014). Other works, have implied WRB to be essential for the formation of synaptic 
structures in photoreceptors and inner ear cells (Daniele et al. 2016; Lin et al. 2016). 
It is still uncertain if the role WRB in these pathologies and cellular processes is 
related to its essential role in the TRC40 pathway or not. 
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1.3.4 Regulation of CAML/WRB 
 
Recently, Colombo and colleagues set out to fill the gap of knowledge that 
remained, concerning the function and reciprocal interactions of CAML and WRB as the 
two subunits of the TRC40 receptor, compared to the extensive understanding of the yeast 
GET system (Colombo et al. 2016). 
Using a series of functional, in-vitro assays, they were able to demonstrate that 
both WRB and CAML are essential for TRC40-dependent TA protein insertion in 
microsomal extracts and that they were sufficient to confer insertion competence to 
liposomes. Furthermore, it was demonstrated that CAML and WRB indeed physically 
interact and that immune-depletion of CAML from microsomal extracts, also depletes 
WRB and renders the microsomal extract incompetent for insertion. 
Then, using a strategy based on the application of recombinant proteins for the 
creation of standard curves, the authors quantified the absolute amount of CAML and 
WRB in rat liver microsomes and in a human neuroblastoma cell line, finding CAML to 
be in large molar excess over WRB (4-fold in microsomes and 7-fold in neuroblastoma 
cells). They also saw that, in-vitro, the excess of CAML does not interfere with TA protein 
insertion. 
Since the WRB gene is present in the distal region of the long arm of chromosome 
21 (Hsa21), which is a region considered to play a critical role in the DS phenotype, the 
authors used a similar strategy to quantify the absolute amounts of CAML and WRB in 
DS and control fetal fibroblasts. They found an increase in WRB, both at the protein and 
the transcript levels, in line with a previously reported 1.5-fold upregulation of Hsa21 
transcripts (Prandini et al. 2007). Additionally, they again saw that an imbalance in 
WRB/CAML protein levels did not impair TA protein insertion. 
In yeast, it had been seen that the deletion of each one of the subunits resulted in 
at least a partial loss of the second subunit (Mariappan et al. 2011) in agreement with the 
concept of quality control (see Section 1.2.2). Thus, to understand if a similar effect was 
observed in mammalian cells, the authors silenced each one of the subunits in HeLa cells, 
using RNA interference. They saw that indeed, also in mammalian cells, the depletion of 
one subunit led to a parallel depletion of the second one (Fig. 1.4-A; B). Subsequently, to 
investigate at which step the expression of each subunit was influenced by the other, they 
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analysed the relative transcript levels after silencing, surprisingly finding that upon 
CAML silencing, the levels of WRB transcript were greatly reduced, while the silencing of 
WRB did not seem to have such a strong effect on the levels of CAML transcript (Fig. 1.4-
C; D). Furthermore, the authors showed that the reduction in WRB transcript following 
CAML silencing was caused by its destabilization (Fig. 1.4-E). The strong effect of WRB 
silencing on CAML protein and the very mild effect on transcript levels were instead in 
line with results obtained from a conditional knockout mouse for WRB, which has 
reduced levels of CAML protein but not alterations in CAML transcript (Rivera-Monroy 
et al. 2016). 
The destabilization effect of CAML silencing on WRB transcript and the causes 
for the reduced protein levels upon partner silencing are still to be better elucidated. The 
investigation of these regulatory mechanism will be the main focus of the present work. 
The last chapter of this introduction is dedicated to mechanisms of post-transcriptional 
regulation, in order to provide a background for my studies on the regulation of the WRB 
transcript. 
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Fig. 1.1 - Effect of the silencing of the TRC40 receptor subunits on each other. The silencing of CAML leads 
to the reduction of WRB protein (A) and transcript (B) levels, by destabilizing its transcript (E). The 
silencing or WRB leads to the depletion of CAML protein (B) and a small reduction of its mRNA levels (D). 
Adapted from (Colombo et al. 2016). 
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1.4 Post-transcriptional regulation 
 
From the moment it is transcribed, RNA passes through several steps of 
maturation and regulation until and while it is finally translated into protein. These steps 
include RNA splicing, transport, stability, localization and translation, which ultimately 
determine the amount and subcellular localization of the translated protein, thus 
impacting the cellular response to stimuli and stress. The multitude of regulatory 
mechanisms of mRNA fate can be appreciated in Fig. 1.5. 
RNA regulation factors can be divided in two major categories, RNA-binding 
proteins (RBP) and non-coding RNA. Right from when transcription initiates, these 
factors dynamically bind the RNA forming the messenger ribonucleoprotein particle 
(mRNP). Most RNA regulation factors, are targeted to structures or sequences that are 
mRNA specific; these recognition elements are commonly present in the untranslated 
regions (UTR) of mRNA, at the 5’ and 3’ ends of the transcript. It is the unique 
combination of factors accompanying each mRNA, as well as their relative position along 
the transcript, that dictates the fate of every mRNA (Moore 2005). 
Eukaryotic RNA, immediately after transcription is referred to as precursor-
mRNA (pre-mRNA), which then needs to be processed to become functional mRNA. The 
first post-transcriptional modification to which pre-mRNAs are subjected is 5’capping. 
This consists of the addition to the 5’ end of the pre-mRNA of a 7-methylguanosine 
through a 5’-5’-triphosphate linkage. The 5’cap is important for several aspects of mRNA 
fate. It serves to protect mRNAs from exonuclease 5’-to-3’ degradation, both in the 
nucleus and the cytoplasm (Stevens and Poole 1995; Jinek et al. 2011). It is also necessary 
for efficient translation, serving as a binding site for various eukaryotic initiation factors 
(eIFs) and promoting the assembly of the pre-initiation complex (Jackson et al. 2010). 
Another step in mRNA maturation is intron removal and exon splicing. Splicing 
is performed by the spliceosome and can result in alternative splicing, giving rise to 
different mature mRNAs. The exon-exon junctions resulting from splicing are bound by 
the exon junction complex (EJC), a protein complex that can either positively influence 
translation when it is bound in the open reading frame (ORF) or target the bound mRNA 
for rapid destruction via nonsense-mediated mRNA decay (NMD) when bound to the 
mRNA 3’UTR (Tange et al. 2004). 
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The last mRNA modification during maturation is polyadenylation. In this 
process, the pre-mRNA is first cleaved between the highly conserved AAUAAA sequence 
and a degenerate U/GU rich sequence, after which the poly(A) polymerase adds a 3’ 
poly(A) tail of ~200 nucleotides (Minvielle-Sebastia and Keller 1999). Polyadenylation 
can take place in different sites of the mRNA, creating multiple mRNA isoforms by 
alternative polyadenylation. The poly(A) tail provides the mRNA with a binding site for 
poly(A) binding proteins (PABP), a class of regulatory proteins that influence mRNA 
export, stability and decay, and translation (Mangus et al. 2003). 
During and after mRNA maturation, several regulatory factors bind to mRNA, 
promoting its transport across the nuclear pore complex and into the cytoplasm and then 
promoting interaction with the translation machinery. As it is transiting the pore or soon 
after reaching the cytosol, a change in mRNP composition takes place, with some nuclear 
export proteins detaching from the mRNA and a concomitant engagement of the 
translation machinery. Some mRNAs have even been seen to associate with multiple 
ribosomes while still transiting the nuclear pore (Moore 2005). 
Fig. 1.2 - Representation of the various layers of post-transcriptional regulation that dictate the fate of 
mRNAs (Glisovic et al. 2008). 
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Interestingly, a model has been proposed - thoroughly reviewed by Keene (2007) 
– that eukaryotes may present an operon-like regulation mechanism, where multiple 
mRNAs coding either for interacting or co-localized proteins can be bound together by a 
common RBP that is responsible for the physical proximity of the various transcripts, 
allowing a co-regulation of those mRNAs. This could for example be favourable for the 
assembly of multi-subunit protein complexes, recreating the simpler situation observed 
in prokaryotes, where these complexes are expressed in polycistronic mRNAs (see Section 
1.2.1 and Fig. 1.1). 
Translation of mRNA is controlled by a number of factors, including a network 
of simultaneous interactions between the 5’cap and eIFs present in the 5’ UTR and the 
PABPs in the poly(A) tail of the 3’UTR. Two of the most well studied examples of 
modulation of translational efficiency are the internal ribosomal entry sites (IRES) and 
upstream ORFs (uORFs). IRES are mRNA regulatory motifs that facilitate a cap-
independent mechanism of translation initiation, in which the ribosome binds to an 
internal site close to the translation initiation site (Filbin et al. 2009). IRES promote the 
recruitment of ribosomes and continued translation of essential proteins under 
conditions when cap-dependent translation is inhibited by stress, cell-cycle stage or 
apoptosis. 
An uORFs is a 5’UTR regulatory mechanism. It occurs when an AUG is present 
in the 5’UTR, upstream to the main start codon, with an in-frame stop codon. In mRNAs 
that contain uORFs, the translational machinery may translate the uORF, altering the 
efficiency of translation of the main ORF, potentially causing great reductions in protein 
expression levels (Meijer and Thomas 2002). It has also been proposed that uORFs may 
relate to NMD, implying that the mechanism of uORF reduction of translation of the 
main ORF is more complex than previously thought (Mendell et al. 2004). 
If the 5’UTR mostly carries motifs important for the regulation of translation, the 
3’UTR can be seen as a regulatory hub, responsible for regulation of numerous processes 
including transcript cleavage, stability, degradation, polyadenylation, translation and 
mRNA localisation (Barrett et al. 2012). The 3’UTRs have the sequence targets for 
miRNAs, small non-coding RNAs that interact with their targets to regulate the 
expression. They also carry binding motifs for several RBPs, of which one of the most 
well-studied examples are the AU-rich elements (ARE). AREs are described as 
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stabilisation elements ranging from 50-150 bp and generally containing multiple copies 
of the pentanucleotide AUUUA (Chen and Shyu 1995). Different RBPs, or a RBP 
subjected to different stimuli, can bind AREs and result in different outcomes for the 
bound mRNA (Barrett et al. 2012). 
Another important step in the life cycle of mRNA is degradation. This is true both 
for the degradation of aberrant mRNAs and for degradation during natural mRNA 
turnover. As commented in a previous section (see Section 1.2.2) regarding proteins, also 
for mRNA, the accumulation of defective mRNAs can have deleterious impacts on the 
cell by resulting in the translation of inappropriately terminated proteins. Moreover, 
when a protein is no longer needed, the transcript present in the cell must be degraded to 
stop expression. The degradation mechanisms are known to be intimately connected with 
translation and are regulation by a complex network of RBPs, including those that are 
responsible for the translation initiation itself. During natural transcript turnover, the 
mRNA is deadenylated and then can either be degraded 3’ to 5’ by the exosome or, more 
commonly, undergo decapping followed by 5’ to 3’ exonuclease degradation. Different 
quality control pathways exist for the degradation of aberrant mRNAs, these pathways 
are usually induced after the first round of translation: transcripts containing a premature 
stop signal undergo NMD which leads to deadenylation-independent decapping and, in 
metazoans, endonuclease cleavage; transcripts that lack a termination codon altogether 
are degraded via non-stop decay resulting in 3’ to 5’ exonucleolytic decay; and mRNAs 
that present strong stalling in translation elongation can be cleaved by endonuclease 
activity (reviewed in Wilusz et al. 2001; Shoemaker and Green 2012).  
In eukaryotic cells, when translation is finished, polysomes are disassembled and 
non-translating mRNPs are targeted to specialized, non-membrane cellular 
compartments for storage or degradation. These compartments are composed of non-
translating mRNPs and can either have several mRNA decay factors or translation 
initiation factors. Due to their composition, there has been much discussion as to the 
classification and function of these compartments, but the current status is that three 
kinds of compartments can exist, based on protein and mRNA composition, and genesis: 
processing bodies (P-bodies), GW-bodies and stress granules (Anderson and Kedersha 
2006; Decker and Parker 2012; Patel et al. 2016). P-bodies in yeast were initially also called 
GW-bodies in higher eukaryotes due to the presence of Gw/GW182, a protein that is not 
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conserved in yeast. For long, these were thought to be the same homologous entity, 
however, recent evidence proposes a composition and function-based divergence, 
suggesting that both compartments can exist in higher eukaryotes. Both have been seen 
to be composed of translation repressor and several mRNA degradation factors such as 
exonucleases, decapping and deadenylation factors and modulators, among others. 
Supporters of the diverging model point out the presence of Gw/GW182 as a determinant 
factor for the GW-body as an entity on its own, because of its ability to recruit Ago-1 - a 
member of the microRNA-induced silencing complex (RISC) - and consequently the 
recruitment of RISC-targeted RNAs, implying an additional function of GW-bodies in 
miRNA-mediated silencing (Patel et al. 2016). Moreover, while P-bodies are thought to 
never associate with membranes, GW-bodies have been reported to interact with endo-
lysosomal compartments and even to be secreted in exosome-like vesicles (Gibbings et al. 
2009). Stress granules, on the other hand, are formed under stress conditions or when 
translation is artificially blocked. When cells are subjected to stress, the translation, 
especially of housekeeping genes, is shut down, while genes important for the stress 
response and for the adaptation of the cell to the new environment are upregulated; these 
include chaperones, and enzymes responsible for damage repair. In this process, stalled 
transcripts aggregate forming complexes containing several translation initiation factors, 
the small ribosomal subunit and several other RBPs. Transcripts can shuttle between P-
bodies and stress granules, maybe undergoing degradation in the former, and being 
stored for future use in the latter; indeed, when the stress disappears or the cells adapt to 
the stress, these transcripts can return to the cytoplasm, resuming translation (Anderson 
and Kedersha 2006; Protter and Parker 2016). 
It must be noted that the relationship between mRNA degradation pathways and 
P-body formation has been recently cast into doubt (Hubstenberger et al. 2017), and 
further work should address the real contribution of P-bodies for mRNA degradation and 
storage.  
Here are described only some of the numerous layers of post-transcriptional 
regulation of mRNAs, to show the diversity of mechanisms by which different transcripts 
can be independently or co-regulated. The fundamental objective of these incredibly 
complex regulatory networks is efficient and localized protein translation and mRNA 
turnover. 
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AIM OF THE THESIS 
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Protein complexes represent a significant portion of the cellular targets of drugs. 
To be able to discover and design new and improved compounds for pharmacological 
therapies, one must better understand the very essence of the targeted receptors, 
including the molecular and cellular mechanisms that govern not only their response to 
the substance being used but also their biogenesis, assembly, subcellular localization and 
stability. 
In the last decades, a great deal has been learned about proteins and protein 
structures. The application of multiple biophysical techniques, including X-ray 
crystallography, NMR and cryo-electron microscopy (2017 Nobel prize for chemistry), 
has allowed the determination of an ever-growing number of protein structures, 
including those of oligomeric protein complexes. This has led also to the determination 
of the interactions between subunits and the structural changes they undergo when 
forming a complex. Nevertheless, the regulatory mechanisms that govern the assembly of 
a multi-subunit protein complex, including spatio-temporal relations with the process of 
their translation on ribosomes, remain rather poorly understood. 
In this work, as example of an oligomeric protein complex, we studied the 
regulation of the synthesis and assembly of the TRC40 receptor. The TRC40 receptor, a 
heterodimer composed of the WRB and CAML subunits, is responsible for the post-
translational insertion of tail-anchored proteins into the ER membrane. It was recently 
found that this heteromeric receptor presents an inter-subunit transcript-protein cross-
talk that could be important for the expression and assembly of the final complex. Thus, 
we intend to study this receptor expression, with the aim of understanding how the 
regulation of the expression of each subunit could be modulated by the second one. Our 
findings could be important in describing a new system for the co-regulation of the 
expression of the subunits of a protein complex. 
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MATERIALS AND 
METHODS 
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3.1 Cell culture and manipulation 
 
3.1.1 Cells 
 
HeLa cells were the first immortalised human cells, derived from a human 
epidermoid carcinoma of the cervix in 1951 (Scherer et al. 1953). Since then, the use of 
this epithelial cell line as cell model became widely spread, due to their resistance and to 
the easiness in their handling. In this work, these cells were the model chosen to study the 
regulation of the expression of the WRB/CAML complex; they were used for steady-state 
analysis of transcripts and proteins, as well as for gene overexpression and silencing 
experiments. 
HeLa cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, 
Invitrogen) supplemented with 10 % (v/v) of heat-inactivated Fetal Bovine Serum (FBS, 
Carlo Erba), 1% (v/v) penicillin/streptomycin antibiotic mix (P/S, Invitrogen) and 1% 
(v/v) L-glutamine (Invitrogen). Cells were kept at 37 ºC and 5 % CO2 in a humidified 
incubator and routinely subcultured when optimal confluence was reached. 
 
3.1.2 Transcription inhibition 
 
For studies on transcript stability, transcription was inhibited using 5,6-dichloro-
1-b-D-ribofuranosylbenzimidazole (DRB, Sigma). DRB inhibits transcription by 
inhibiting transcription elongation by RNA polymerase II (Sehgal et al. 1976; Dubois et 
al. 1994). Transcript stability was studied by inhibiting transcription for different time 
periods and analysing the mRNA levels at each time point.  
For this, cells were seeded at ~35% confluency in 28 cm2 culture dishes, one culture 
dish for each of the seven time points (t = 0; 0.5; 1; 2; 4; 6 and 8 hours). The next day, the 
cells from t = 0 were washed twice with Phosphate-buffered Saline (PBS – 137 mM NaCl; 
2.7 mM KCl; 10 mM Na2HPO4; 1.8 mM KH2PO4) for removal of serum proteins and then 
harvested for RNA extraction by scraping in PBS. The cells were then transferred into a 
tube and pelleted by centrifugation at 850 g for 10 minutes at 4 ºC. The supernatant was 
discarded and the pellet was frozen in liquid nitrogen and kept at -80 ºC until use. 
Meanwhile, the medium of the cells of each of the other time points, was collected 
together and DRB was added (60 µM). The medium containing DRB was then divided by 
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the various culture dishes and the cells were incubated for the indicated times. At the end 
of incubation, cells were harvested and frozen as described above. 
For the study of CAML transcript stability upon WRB silencing, three 3.8 cm2 
wells with HeLa cells were silenced for each DRB time point, and DRB treatment was 
initiated ~68h after WRB silencing. After incubation, cells from the three wells were 
harvested together in the same tube, as above. 
 
3.1.3 Transfection 
  
Different transfection methods are available for the insertion of external nucleic 
acids into cells. In this work chemical transfection was used, taking advantage of two 
different transfection reagents, for the introduction of either plasmid DNA for transient 
gene overexpression or small interfering RNA (siRNA) for gene silencing. 
 
3.1.3.1 Gene silencing 
 
Silencing of WRB or CAML was achieved by RNA interference. In this technique, 
the mRNA of a gene is degraded or its translation is blocked, in each case preventing the 
expression of the gene. In this work, RNA interference was performed using siRNAs, 
which are small double stranded RNAs, typically ranging from 20-25 nucleotides that are 
designed to specifically target the gene intended to be silenced. When introduced in the 
cell, one of the single stranded RNA fragments is loaded into the RISC complex activating 
it. The siRNA is then used by RISC to scan the mRNAs in the cell until the target is found 
and the Argonaute protein, one of the RISC components proceeds with the target mRNA 
degradation. The siRNAs (Invitrogen) used in this work are listed in Table 3.1. In each 
silencing experiment, a parallel sample is treated with a scramble siRNA (siSCR), that 
does not target any known human gene, as control. 
The siRNAs were delivered to the cell using the Lipofectamine™ RNAiMAX 
transfection reagent (Invitrogen).  
For silencing experiments, HeLa cells were seeded 24 h prior to the silencing at 
~8% confluency in an antibiotic-free DMEM in 12-well plates, the day after, before 
silencing, fresh medium was added to the cells.  
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For CAML silencing, 10 pmol of siCAML or of siSCR was diluted in a tube with 
opti-MEM I Reduced Serum Media (opti-MEM, Gibco) in a final volume of 100 µL and 
1 µL of Lipofectamine RNAiMAX was diluted with opti-MEM in a second tube in a final 
volume of 100 µL. The two dilutions were gently mixed and spun before adding the 
siRNA dilution to the Lipofectamine tube. After this, the reaction was mixed gently, spun 
and incubated for 20 minutes at room temperature to allow for complex formation. After 
incubation, complexes were gently added to the cells in a drop-wise manner. Cells were 
incubated with the complexes at 37 ºC and 5 % CO2. After 6h of incubation the medium 
was substituted with antibiotic supplemented DMEM and the cells were allowed to grow 
for 48h before being harvested for western-blot analysis or subjected to additional 
treatment.  
Cells intended for SDS-PAGE and western blot analysis were washed twice with 
PBS for removal of serum proteins and harvested by direct lysis with hot Lysis Buffer (1% 
[w/v] SDS; 10 mM Tris-HCl pH 8.6; 1 mM PMSF; protease inhibitor cocktail [PIC]) and 
proteins were further denatured with the addition of 0.5 volumes of Denaturation Buffer 
(DB) 3X (3 % b-Mercaptoethanol; 25.5 % glycerol; 6% SDS; 60 mM Tris-HCl pH 6.8; 0.03 
% Bromophenol blue). Samples were then boiled for 2 minutes at 100 ºC and either used 
immediately or stored at -20 ºC until use.  
For WRB silencing, the same procedure was followed with a few changes. 10 pmol 
of siWRB or siSCR were mixed with 2 µL of Lipofectamine RNAiMAX and, after addition 
of complexes, cells were grown for 68-72h before being harvested for western-blot 
analysis as described above or being subjected to additional treatment. 
The efficiency of silencing was analysed as a function of protein or transcript level 
in silenced cells relative to cells treated with siSCR. 
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Oligo Sequence (5’-3’) 
Primer 1 ttaagcttggcgcttggcttcaccg 
Primer 2 cttaatgtttttggcatcttcc 
Primer 3 gctctagagctgaacaggaggatggata 
Primer 4 gctctagaagtgagaaaattcagctttactggg 
Primer 5 gtctagagcactgttttgttttttaaga 
Primer 6 gctctagatggaatttttagtagtgg 
Primer 7 gcgagcacagaattaatacgact 
Primer 8 cagccgcgaggctaaaaaac 
Primer 9 cgcggatccaattaatacgactcactatagg 
Oligo 1 agcttgggtggggcgcttggcttcaccgcgcaggcgcggtcgccgctgttgttgtggtccccat 
ggagctgccgtagcggacccagcacagccaggagcgtccgggccca 
Oligo 2 agcttgggcccggacgctcctggctgtgctgggtccgctacggcagctccatggggaccacaacaa 
cagcggcgaccgcgcctgcgcggtgaagccaagcgccccaccca 
Oligo 3 agcttgggtggggcgcttggcttcaccgcgcaggcgcggtcgccgctgttgttgtggtccccGtCgag 
ctgccgtagcggacccagcacagccaggagcgtccgggccca 
Oligo 4 agcttgggcccggacgctcctggctgtgctgggtccgctacggcagctcGaCggggaccacaaca 
acagcggcgaccgcgcctgcgcggtgaagccaagcgccccaccca 
siCAML gcgcggaagaagaaagucatt 
siWRB ggguaguaagugucgcuuutt 
 
3.1.3.2 Transient gene overexpression 
 
Transient gene overexpression was carried out with the use of the jetPEI 
transfection reagent (Polyplus transfection). jetPEI is a polyethylenimine polymer able to 
create very stable, positively charged, complexes with DNA. 
Transient transfections where used to study the expression of WRB-HA and 
FLAGCAML in CAML and WRB silenced cells, respectively. 
Transfection of WRB-HA or FLAGCAML, was carried out after silencing of 
CAML (48h) or WRB (72h), respectively in 12-well plates. Before transfection, fresh 
medium was added to the cells. To control for transfection efficiency, pEGFPN1 was co-
transfected with WRB-HA and FLAGCAML.  
For the preparation of complexes, 1 µg of either pRK5rs-WRB-HA or pCLX31.1-
FLAGhCAML and 0.5 µg of pEGFPN1 were diluted in a tube containing 150 mM NaCl 
in a final volume of 50 µL and 4.5 µL of jetPEI were diluted in a second tube in 150 mM 
NaCl in a final volume of 50 µL. The two dilutions were vortexed and spun before adding 
the jetPEI dilution to the tube containing the DNA. The mixture was then vortexed, spun 
Table 3.1 - Oligonucleotides used in this study. See text for details. 
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and incubated for 20 minutes at room temperature, to allow for the formation of 
complexes. After incubation, the complexes were gently added to cells in a drop-wise 
manner. Cells were allowed to grow in the presence of the complexes for 24h, before being 
harvested for western-blot analysis as described (see Section 3.1.3.1).  
Luciferase constructs carrying WRB UTRs were transfected in either non-silenced 
or CAML silenced cells to investigate the effect of CAML on luciferase expression by each 
of WRB UTRs. Each of the pTKpGL4.11 constructs were co-transfected with the phRG-
B plasmid, which encodes the Renilla luciferase and was used for transfection efficiency 
normalization.  
In these experiments, 100 ng of phRG-B was co-transfected with a 5-fold molar 
excess of pTKpGL4.11 based plasmids, using 2.55 µL of jetPEI for complex formation. 
For preparation of complexes, the same procedure was used as above. Luciferase activity 
was measured 24h after transfection.  
Cells intended for analysis with the Dual Luciferase Assay were washed twice with 
PBS before being detached by incubation with PBS with 1 mM EDTA at 37 ºC for 5 
minutes. Cells were then harvested and transferred into a tube and pelleted by 
centrifugation at 850 g for 10 minutes at room temperature. Residual EDTA was 
eliminated from the pellet by addition of PBS followed by another centrifugation. Cells 
were then lysed in 1X Passive Lysis Buffer (PLB) as part of the Dual Luciferase Reporter 
Assay System (Promega) manufacturer’s protocol. 
 
 
 
 
 
 
 
 
 
 
 
	 47	
3.2 Molecular biology techniques 
 
3.2.1 Construct preparation 
  
 The basic molecular biology techniques applied in this work for the preparation 
of constructs were performed according to the Current Protocols of Molecular Biology 
(Ausubel et al. 2001), for the exception of when commercially available kits were used 
following manufacturer’s protocols. 
 
3.2.1.1 Polymerase Chain Reaction 
 
Polymerase chain reaction (PCR) is a technique that allows for the very specific 
amplification of a fragment of DNA. It is based on the process of DNA replication, which 
consists in repeated cycles of denaturation and replication of a DNA template, in which a 
Polymerase produces a complementary copy of a single stranded DNA sequence, if 
guided by the presence of a primer that first anneals to the template sequence. 
In this study, mainly two different commercially available DNA polymerases were 
used. The GoTaq® DNA Polymerase (Promega) was used for standard control PCRs and 
the Expand™ High Fidelity PCR System (Roche) that exhibits proofreading activity was 
used for the amplification of sequences intended for subsequent cloning into expression 
vectors. Both enzymes were used following the manufacturer’s protocols, calibrating the 
annealing temperature according to the primer pair being used. The various primers used 
for the preparation of the constructs used in this work are described in (Table 3.1). PCRs 
were performed in a PTC-100 thermal cycler (Bio-Rad). 
 
3.2.1.2 Restriction Enzyme Digestion 
 
For this study, restriction enzymes where used both in the cloning of determined 
DNA sequences into expression vectors and to control that the cloning was successful. 
Generally, in 20-50 µL reaction volumes, 0.2-2 µg of DNA was mixed, never 
exceeding 0.1 µg/µL of DNA concentration, with water, 1X of the recommend buffer for 
the enzyme being used and a 5-fold excess of enzyme over DNA quantity (U/µg). 
Reactions were carried for 2 h at 37 ºC. When digesting plasmids for subsequent insertion 
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of DNA fragments, at the end of the incubation, 1U of Thermosensitive Alkaline 
Phosphatase (TSAP) (Promega) was added per µg of DNA for 30 minutes at 37 ºC for the 
removal of phosphate groups from 5’ ends. The phosphatase was then inactivated by 
incubating the sample at 74 ºC for 15 minutes.  
After digestion, a fraction of the sample was controlled by electrophoresis on an 
agarose gel. 
 
3.2.1.3 Agarose gel electrophoresis 
 
Agarose gel electrophoresis is the most utilized technique to separate, identify and 
purify DNA fragments based on their length. To visualize the fragments, usually an 
intercalating fluorescence probe, e.g. Ethidium Bromide (EtBr), is used. 
For this work, 0.8-2 % agarose gels were prepared in Tris-acetate buffer (TAE – 40 
mM Tris acetate; 2 mM EDTA) with 0.5 µg/mL of EtBr. Fluorescence from EtBr was 
detected using a UV transilluminator (UVITEC) and images of the gels were acquired 
using a UVIsafe HD5 imaging system (UVITEC).  
 
3.2.1.4 Purification of DNA fragments 
 
 DNA fragments, intended for subsequent insertion into expression vectors, 
resulting either from PCR amplification or from digestion from other plasmids, were 
purified, prior to the ligation step, for removal of enzymes, buffers and other unwanted 
DNA fragments. Purification was carried by binding of DNA fragments to silica 
membranes followed by removal of contaminants and subsequent elution of purified 
DNA from the membranes. In this work, the NucleoSpin® Gel and PCR Clean-up Kit 
(Macherey-Nagel) was used, following the manufacturer’s protocol, to purify DNA 
fragments either directly from PCR samples or after separation by agarose gel 
electrophoresis. 
 
3.2.1.5 Ligation of DNA fragments to plasmid vectors 
 
When cloning a DNA fragment into a plasmid vector, the fragment is ligated to 
the plasmid using a DNA ligase, which is an enzyme that can catalyse the formation of a 
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phosphodiester bond between two DNA strands. This ligation happens between two 
fragments that have either sticky, complementary ends or blunt ends.  
In this work, the T4 DNA Ligase (Invitrogen) was used. Briefly, in a 20 µL reaction 
volume, 30 ng of linearized vector were mixed with a 10-fold molar excess of the fragment 
to be inserted, 2 µL of 10X Ligase buffer and 1 U of T4 DNA ligase. The reaction was then 
incubated in a water bath at 16 ºC overnight. The resulting ligation product was then 
transformed into competent E. coli. 
 
3.2.1.6 TA-cloning 
 
 The DNA polymerases used in this work produce an amplicon that presents single 
3’ adenine overhangs. To allow for direct cloning of these DNA fragments, the TOPO® 
TA cloning® Kit (Invitrogen) was used. This kit uses a strategy based on the utilization of 
a topoisomerase that catalyses the ligation between the PCR product adenine overhangs 
and the previously linearized pCRII-TOPO thymidine overhangs. The newly formed 
plasmids can then be transformed into competent bacteria 
 The resulting plasmids were either used to sequence the PCR product or to 
facilitate restriction digestion of restriction sites flanking the amplicon for subsequent 
sub-cloning into an expression vector. 
 
3.2.1.7 Preparation of competent bacteria 
 
 In order to allow the transformation of E. coli with plasmid DNA, these must be 
rendered competent. This can be achieved by treating the bacteria with a divalent cation 
- usually Ca2+ - solution. The divalent cation, neutralizes the negative charges of the DNA 
and helps permeabilize the bacterial wall, allowing the DNA to enter the bacteria. In this 
work, the DH5a strain of E. coli was used. To turn it competent, a bacterial colony grown 
in an antibiotic free lysogeny broth (LB) agar plate (1.5 % [w/v] Agar; 1 % [w/v] Tryptone; 
0.5 % [w/v] Yeast extract; 1 % [w/v] NaCl; pH 7) overnight was inoculated into 100 mL 
of Super Optimal Broth (SOB) medium (2 % [w/v] tryptone; 0.5 % [w/v] Yeast extract; 
0.05 % [w/v] NaCl; 2.5 mM KCl; pH 7.2) with 20 mM MgSO4 and bacteria was grown at 
37 ºC under strong agitation until mid-log phase (OD600 ~ 0.1). After this, the suspension 
was incubated on ice for 10 minutes before being centrifuged at 3220 g for 10 minutes at 
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4 ºC. Then, the pellet was carefully resuspended in 40 mL of ice-cold Frozen Storage 
Buffer (FSB - 45 mM MnCl2; 10 mM CaCl2; 100 mM KCl; 3 mM Hexaamminecobalt (III) 
chloride; 10 mM Potassium acetate, pH 7.5; 10 % [w/v] glycerol; pH 6.4) and incubated 
on ice for 10 minutes before being centrifuged again at 3220 g for 10 minutes at 4ºC. The 
pellet was resuspended in 8 mL FSB, and 140 µL of DMSO were added for cryo-
preservation. The suspension was incubated on ice for 15 minutes and then another 140 
µL of DMSO were added. After this, aliquots of competent bacteria were fast-frozen in 
liquid nitrogen. The competent bacteria were kept at -80 ºC until needed for 
transformation. 
 
3.2.1.8 Transformation of plasmid DNA into competent bacteria 
 
For the transformation of bacteria with plasmid DNA, cells are subjected to a heat-
shock treatment, that helps the DNA enter the bacteria. Plasmid DNAs confer to the 
bacteria a resistance for a determined antibiotic, which is then added to the growth media, 
allowing for selective growth of only transformed bacteria. 
Briefly, 1 ng of plasmid DNA, 10 µL of ligation product or 6 µL of TA-cloning 
product, were mixed with 100 µL of Competent DH5a E. coli and kept on ice for 30 
minutes. The mixture was then placed in a water bath at 42 ºC for 90 seconds and then 
placed back to ice for 1 minute. At this point, 900 µL of LB medium was added to the 
transformed bacteria and the suspension was kept for 1 hour at 37 ºC under agitation. 
After this, 100 µL of the suspension was spread onto a selective LB plate containing an 
appropriate antibiotic, when plasmid was being transformed. When a ligation or TA-
cloning product were being transformed, the bacterial suspension was centrifuged for 5 
minutes at 1000g, then resuspended in a small volume of supernatant, so that the 
complete transformation sample could be spread onto the selective LB plate. 
 Plasmid DNA extracted from selected bacterial colonies grown after 
transformation, was analysed by electrophoresis, restriction digestion or PCR for 
assessment of overall quality of the plasmid and of insertion and orientation of inserted 
fragment in the case of ligation or TA-cloning products transformation. 
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3.2.1.9 Plasmid DNA extraction from bacteria 
 
 After transformation, the transformed DH5a E. coli were grown in a selective 
medium to amplify the DNA plasmid of interest either in a small of medium scale. The 
plasmid was then extracted and purified. 
 For small scale plasmid extraction, 2 mL of LB with an appropriate selective 
antibiotic (100 µg/mL) was inoculated with a bacterial colony grown overnight at 37 ºC 
on a selective LB agar plate and bacteria was grown overnight at 37 ºC under strong 
agitation. The following morning, 1.4 mL of the bacterial suspension was centrifuged for 
5 minutes at 16560 g at 4 ºC. The remaining bacteria were stored at -80 ºC in a 40 % 
glycerol suspension. The pellet was then resuspended in 100 µL of resuspension buffer 
(50 mM Tris-HCL, pH 8.0; 10 mM EDTA; 100 µg/mL RNase A) and vortexed for 
complete resuspension. Then, bacteria were lysed by the addition 150 µL of alkaline lysis 
buffer (200 mM NaOH; 1 % SDS) and the contents were gently mixed by inverting the 
tube. After this, the lysate was neutralized by the addition of 150 µL of neutralization 
buffer (3 M potassium acetate, pH 5.5) and incubated 5 minutes on ice. The lysate was 
then cleared from genomic DNA by centrifugation at 16560 g for 5 minutes at 4 ºC. The 
cleared lysate was then transferred to a new tube and plasmid DNA was precipitated by 
mixing with 800 µL 100 % (v/v) EtOH and centrifugation at 16560 g for 20 minutes at 4 
ºC. The DNA pellet was then washed with 500 µL of 70 % (v/v) EtOH followed by 
centrifugation at 16560 g for 10 minutes at 4 ºC. The pellet was then allowed to dry and 
resuspended in 30 µl Tris-EDTA buffer (TE - 10 mM Tris-HCl, pH 8.0; 1mM EDTA). 
The plasmid DNA extracted from small scale preparations was mostly used for analysis 
of ligation products by restriction digestion and in some cases for DNA sequencing. 
 Medium scale plasmid extraction was used when preparing plasmids for 
subsequent sub-cloning or for end-point applications, such as plasmid transfection. 
Medium scale preparations were performed on 100 mL bacterial suspensions grown 
overnight in the presence of an appropriate selective antibiotic, using the QIAGEN® 
Plasmid Midi Kit (Qiagen), following the manufacturer’s protocol. 
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3.2.1.10 Constructs 
 
The constructs and primers used in this work are illustrated in Fig. 3.1 and Table 
3.1, respectively.  
pRK5rs-WRB-HA was a kind gift from Fabio Vilardi (University of Göttingen, 
Göttingen, Germany), and its preparation had been previously described elsewhere 
(Vilardi et al. 2011); it consists of the WRB coding sequence fused to a C-terminal HA 
tag. The pCLX31.1-FLAGhCAML, containing the CAML coding sequence fused to a N-
terminal FLAG tag (Holloway and Bram 1996) had been provided by Richard Bram 
(Mayo Clinic, Rochester, USA). 
pEGFN1 (Clontech) was available in the laboratory and codes for the enhanced 
Green Fluorescent Protein (eGFP). 
The phRG-B and pTKpGL4.11 were kind gifts from Roberta Benfante (IN-CNR, 
Milan, Italy). phRG-B is a promoterless mammalian vector that encodes a humanized 
Renilla luciferase. pTKpGL4.11 encodes the firefly luciferase under the Thymidine Kinase 
(TK) promoter. 
The constructs used to study the effect of WRB UTRs in expression were built on 
the pTKpGL4.11 backbone. The sequence of the WRB transcript deposited on NCBI 
database (NM-004627) was used as reference for the preparation of a synthetic 
oligonucleotide cassette containing the WRB 5’UTR sequence flanked by cohesive ends 
complementary to the HindIII restriction site (oligo 1 and oligo 2 in Table 3.1). Due to 
the presence of an ATG sequence in WRB 5’UTR, a second oligonucleotide cassette 
(oligo3 and oligo 4 in Table 3.1) was prepared, in which that ATG was changed into GTC; 
this cassette was called WRB 5’mutUTR. The pTKpGL4.11-WRB5’UTR and 
pTKpGL4.11-WRB5’mutUTR were prepared by inserting each one of the synthetic 
oligonucleotide cassettes into the HindIII restriction site of pTKpGL4.11, present 
upstream to the luciferase coding sequence. The insertion and correct orientation of the 
cassette in the plasmid was controlled by PCR, using primers 1 and 2; the amplification 
of a DNA fragment reported on the correct orientation.  
The same WRB transcript sequence was used to design a primer pair, primers 3 
and 4, that carried a 5’-end XbaI restriction site, to amplify WRB 3’ UTR from cDNA 
retrotranscribed from HeLa cell RNA. The amplified WRB 3’ UTR was first sub-cloned 
in a TA-cloning vector and sequenced. After confirmation that it was identical to the 
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deposited sequence, the WRB 3’ UTR was excised from the TA-cloning vector using the 
XbaI flanking sites and then cloned into the pTKpGL4.11, pTKpGL4.11-WRB5’UTR and 
pTKpGL4.11-WRB5’mutUTR XbaI site, situated downstream to the luciferase coding 
sequence; the resulting constructs were called pTKpGL4.11-WRB3’UTR, pTKpGL4.11-
WRB5’+3’UTR and pTKpGL4.11-WRB5’mut+3’UTR. The insertion and correct 
orientation of the WRB 3’ UTR fragment was controlled by restriction digestion with 
SpeI: the presence of two closely migrating bands of ~3000bp was indicative of the correct 
orientation. 
The “AREsless” construct, pTKpGL4.11-WRB3’UTRDARE, which has an internal 
portion of WRB 3’ UTR without any of the three putative AREs, was prepared by 
amplifying the 3’RACE product B2 from the pCRII-TOPO vector using primers 5 and 6, 
both primers designed with 5’ end XbaI restriction sites. Primer 5 was designed to be 
complementary to the antisense strand in a region downstream of a potential ARE site 
located in the 5’ region of WRB 3’ UTR. The amplification product was subcloned into 
the TA-cloning vector to be excised by XbaI restriction digestion. The excised fragment 
was then cloned into the XbaI site of pTKpGL4.11. 
 
3.2.2 RT-qPCR 
   
Real-time or quantitative PCR (qPCR) is a PCR (see Section 3.2.1.1) based method 
that allows for the quantification of the initial template present in the reaction. In 
traditional PCR, the amplification product is analysed and quantified after the last cycle, 
without obtaining information on the initial template quantity. In qPCR, on the other 
hand, the amplification product is analysed at the end of each cycle. This is achieved by 
using fluorescent probes that give fluorescent signals proportional to the number of 
amplification molecules generated.  
When combined with reverse-transcription (RT-qPCR), this technique allows to 
measure also the RNA levels in a sample, by first retrotranscribing the RNA into 
complementary DNA (cDNA) and then amplifying the resulting cDNA. By using probes 
that are designed to be highly specific for a gene transcript of interest, one can measure 
the mRNA levels of that gene in a biological sample. These probes have two different 
fluorescent molecules, one at each end of the probe. When in close proximity, one of the 
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two molecules, the quencher, strongly supresses the fluorescence emission of the reporter 
dye in a physical phenomenon called fluorescence resonance energy transfer (FRET). 
When in solution or bound to the target, the two molecules are near and FRET occurs, 
quenching the fluorescence of the reporter dye. However, during PCR using a primer pair 
specific for the target, both primers and probe anneal to the target and then, when the 
target sequence is amplified, the taq polymerase 5’ nuclease activity cleaves the probe 
separating the two molecules. When the two molecules are separated, FRET can no longer 
occur and the reporter dye emits a fluorescence signal. This approach is more specific 
because even if either the primers used or the probe present an off-target annealing, those 
off-targets will not be represented in the result, since for a sequence to be measured, a 
combination of both the primer and the probe annealing are needed. 
In each case, after a certain number of amplification cycles, the fluorescence signal 
will increase sufficiently to be distinguishable from the background signal; this cycle is 
defined as the threshold cycle (Ct). The Ct is inversely proportional to the initial amount 
Fig. 3.3 - Representation of the constructs used in this study. See Section 3.2.1.10 for details. 
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of target, so it can be used to perform an absolute quantification of the number of template 
molecules present in the initial sample, by comparison with a standard curve composed 
of know amounts of target copies, or to perform a relative quantification between the 
template levels of two different samples. 
The relative quantification between two samples is generally performed recurring 
to the DDCt method. In this method, the Ct for the gene of interest is adjusted in relation 
to the Ct of a normalizer gene (usually a housekeeping gene) in each sample. Then, one of 
the samples is used as calibrator (e.g., the t0 of a treatment or the scramble control in 
silencing) and the difference is usually represented by a fold difference (2-DDCt). 
In this work, RT-qPCR was used to measure the relative levels of CAML and WRB 
transcripts using GAPDH as normalizer between samples, and t=0 or scramble samples 
as calibrators in transcript stability or effect of silence on transcript level experiments, 
respectively. 
 
3.2.2.1 RNA extraction 
 
RNA intended for reverse-transcription was extracted and purified from HeLa 
cells (prepared as described in Section 3.2.2) using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. Qiashreder spin columns (Qiagen) and RNase-
free DNase set (Qiagen) were used for lysate homogenization and complete removal of 
genomic DNA, respectively. The procedure yielded generally ~30 µg of RNA that was 
stored at -80 ºC until use. 
 
3.2.2.2 Reverse-transcription 
 
For the quantification of RNA using qPCR, an essential step is the reverse-
transcription of RNA into cDNA using a reverse transcriptase and a reverse transcription 
primer. Depending on the application, this can be achieved using different approaches, 
mainly by changing the kind of primer used. One can retrotranscribe total RNA using 
random hexamer primers, poly(A) RNA by using oligo(dT) primers, and specific RNAs 
using gene specific primers. Strategies for the reverse transcription of small non-coding 
RNAs such as miRNAs are also available. 
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In this work, total RNA extracted from HeLa cells was retrotranscribed using 
Random Hexamers (Euroclone) and SuperScript IV Reverse Transcriptase (Invitrogen). 
Reactions were carried out in a PTC-100 thermal cycler (Bio-Rad). For each sample, 1.5 
µg of RNA was retrotranscribed following the manufacturer’s protocol. The newly 
synthesised cDNA was either used immediately for qPCR or stored at -20 ºC for at most 
a few days. 
 
3.2.2.3 qPCR 
 
Real-time PCR was performed in a QuantStudio 5 System thermocycler (Applied 
Biosystems) using TaqMan Gene Expression Assays (Applied Biosystems) with FAM-
MGB dyes containing a probe and a primer pair, specifically targeted to CAML, WRB or 
GAPDH (Assay IDs: Hs00266143_m1; Hs00190294_m1 and Hs99999905_m1, 
respectively). The TaqMan Gene Expression Master Mix (Applied Biosystems) was used 
to provide the necessary reagents including the taq polymerase. 
For each sample, 1 µL of cDNA was mixed with 1 µL of TaqMan Gene Expression 
Assay and 10 µL of TaqMan Gene Expression Master Mix in a 96-well plate in a final 
volume of 20 µL. Each amplification reaction was performed in triplicate and a non-
template control, in which cDNA was replaced by water was done for each probe. 
The amplification protocol was as follows: first a Hold Stage where samples were 
incubated at 50 ºC for 2 minutes, followed by incubation at 95 ºC for 10 minutes. Then, 
the PCR stage consisted of 40 cycles of an initial denaturation step of 15 seconds at 95 ºC 
followed by a second elongation step of 1 minute at 60 ºC. 
Ct values were obtained using QuantStudio Design & Analysis Software (Life 
Technologies). 
 
3.2.3 Rapid Amplification of cDNA Ends 
 
The amplification of the 3’ UTR of a transcript, of which the 3’ end is not known 
or which, could present multiple polyadenylation variants, is not possible by standard 
PCR amplification, since in these cases it is not possible to design a specific primer for the 
3’ end. Amplification can be achieved using the Rapid Amplification of cDNA Ends 
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(RACE) method. 3’ RACE takes advantage of the poly(A) tail present in mature mRNAs. 
In this procedure, mRNAs are reverse transcribed using an oligo-dT adapter primer that 
contains a poly(T) sequence followed by an adapter sequence.  In this way, all 
polyadenylated mRNA is converted into cDNA. Then, this cDNA is used as template to 
amplify the target by PCR. In the first PCR, the sense primer is a gene specific primer 
while the antisense primer is designed to anneal with the sequence of the oligo-dT 
adapter. This PCR should yield the amplification of the target sequence. Often, however, 
to obtain more material or greater specificity, a second, nested PCR is needed. The 
amplification product can then be cloned as desired. 
In this work, the FirstChoice RLM-RACE kit (Ambion) was used. Briefly, 1 µg of 
RNA extracted from HeLa cells was reversed transcribed using SuperScript IV Reverse 
Transcriptase and 3’RACE adapter for priming. The product of this reaction was then 
used as template for a first PCR using GoTaq® DNA Polymerase and primers 3 and 7 (see 
Table 3.1) for priming. The product of this reaction was then used as template for a second 
PCR using primers 8 and 9 (see Table 3.1) for priming.  
The amplification products yielded in this procedure were then separated by 
agarose gel electrophoresis and purified, before being cloned into the pCRII-TOPO TA-
cloning vector and sequenced. 
 
3.2.4 Dual-luciferase reporter assay 
 
Genetic reporter systems are tools commonly used to study gene expression. Their 
applications range from the study of receptor activity, transcription factors, intracellular 
signaling, protein folding, to mRNA regulation. 
The Dual-Luciferase Reporter Assay System (Promega) applied in this work uses 
the firefly and the Renilla luciferases, measuring the activities of both luciferases 
sequentially in the same sample. 
In this work cells, co-transfected, harvested and lysed as described in Section 
3.1.3.2 were analyzed in 96-well white bottom plates, with the Dual-Luciferase Reporter 
Assay System following the manufacturer’s protocol in a GloMax Discover (Promega) 
luminometer. 
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3.3 Biochemical methods 
 
3.3.1 Immunoprecipitation and Co-immunoprecipitation 
  
 Co-immunoprecipitation (co-IP) is the most straightforward method to study 
protein-protein interaction. This method is based on the immunoprecipitation (IP) 
procedure. In a basic IP, an antibody, specific for the protein of interest, is used to bind 
to that protein in a solution that can have multiple proteins, for example a cell lysate. The 
antibodies are coupled to solid substrates, usually agarose or magnetic beads, either before 
or after incubation with the sample. The solid substrate is then used to collect the 
antibodies, which in turn collect the target proteins, allowing to wash-off the rest of the 
sample where all proteins that did not bind to the antibody remained. The protein can 
then either be eluted from the antibody and analysed or used in other applications. In an 
ideal, completely efficient IP reaction, all the target protein and that protein alone would 
be collected from the initial sample, however the efficiency of precipitation is influenced 
by various factors such as antibody binding affinity, wash stringency, among others. 
 In a co-IP reaction, the same procedure is used, but if the target protein, also 
referred to as bait, interacts with a second protein, that can be called prey, and if the 
interaction is maintained during the reaction, the prey will be “co-precipitated” together 
with the bait. However, co-precipitating the prey is not always easy due to the nature of 
the protein-protein interactions that can be weak or have low-affinity. So, the conditions 
in which the reaction is performed are crucial for a successful co-IP, particularly 
concerning the buffers chosen to lyse the cells and wash the beads. This is especially true 
when handling membrane proteins, due to their tendency to aggregate in solution. In 
these cases, a mild detergent must be used to keep the proteins soluble, but it cannot be 
strong enough to disrupt the protein-protein interaction. 
 In this work, the WRB/CAML complex was co-immunoprecipitated using either 
one of the two subunits as bait. The buffers used for the reaction contained Deoxy Big 
Chaps (DBC), since it had been demonstrated that both CAML and WRB are soluble and 
functional in the presence of this detergent (Colombo et al. 2016). 
 Hela cells, grown to confluency in a 28 cm2 culture dish were washed twice with 
PBS before being harvested by scrapping in PBS. Cells were then pelleted by 
	 59	
centrifugation for 10 minutes at 800 g at 4 ºC. The pellet was resuspended in hypotonic 
buffer (1 mM Tris-HCl pH7.5; 1 mM EDTA; 1 mM KCl; 1 mM NaCl) in the presence of 
protease inhibitors and incubated 10 minutes on ice to promote swelling of the cells by 
osmotic pressure. Swollen cells were homogenized by passing 50 times through a syringe 
needle (26Gx1/2”). Homogenized samples were then solubilized in a DBC containing 
buffer (0.6 % [w/v] DBC; 50 mM Hepes-K+ pH7.4; 250 mM sorbitol; 70 mM potassium 
acetate; 5 mM EDTA; 2.5 mM magnesium acetate; protease inhibitor cocktail) and the 
nuclei were pelleted by centrifugation at 800 g for 10 minutes at 4 ºC. The recovered 
supernatant, referred to as “post-nuclear supernatant” (PNS), was incubated for 1 hour at 
30 ºC  
 Equal aliquots of PNS were then used for co-IP reactions with either anti-CAML 
or anti-WRB antibodies, while one equal aliquot (Input) was immediately mixed with 0.5 
volumes of DB 3X and boiled for 2 minutes at 100 ºC. Each co-IP reaction was composed 
of PNS, a 1:1 protein G agarose slurry and 5 µg/mL of the antibody for the bait protein 
(either WRB or CAML antibody). A control co-IP reaction was performed in parallel, 
where the specific antibody was substituted with 5µg/mL of non-immune rabbit IgG 
(Sigma). The reactions were incubated overnight at 4 ºC with mild agitation. 
 The next morning, the agarose beads were pelleted by centrifugation at 800 g for 
5 minutes at 4 ºC. The supernatant (Unbound) was recovered and immediately mixed 
with 0.5 volumes of DB 3X and boiled for 2 minutes at 100 ºC. 
 The beads were washed, first with the same DBC containing buffer used to 
solubilize the samples and then with double-distilled H2O. After washing, DB was added 
to the beads and the sample (Bound) was then boiled for 2 minutes at 100 ºC. 
 Samples were analysed by western-blot. For this, the entire Bound samples and 
half of both the Input and Unbound samples (50%) were loaded on a 12.5% 
polyacrylamide gel. Only half of the Input and Unbound samples were analysed in order 
to obtain western blot bands within the range expected for those in the Bound sample to 
allow for a better comparison, considering that the immunoprecipitation process is 
frequently poorly efficient. 
 The bands corresponding to each protein were quantified, the values for those 
corresponding to the Input and Unbound samples were multiplied by two, and the IP 
efficiency was determined by two different methods.  
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Method 1: 
 
 𝐼𝑃#$$%&%'(&)(%) = .%/(0123456	85	9:;	<.%/(0123456	85	9=>(.%/(0195?4@) 	×100 
 
 
 
Method 2: 
 
 𝐼𝑃#$$%&%'(&)(%) = .%/(0195?4@		<.%/(01D5E3456	85	9:; <	 .%/(0195?4@	<.%/(01D5E3456	85	9=>.%/(0195?4@ 	×100 
 
 
Method 1 considers the signal of the protein bound to the beads, from which is 
subtracted the signal obtained in the IgG sample to correct for unspecific binding. 
However, this value may be underestimated due to protein loss during washes. 
Furthermore, the lanes containing the bound fraction have a much higher background, 
which makes the quantification more difficult. 
 Method 2 on the other hand considers the signal of the protein present in the 
Unbound sample, and subtracting it from the signal in the input, indirectly estimates the 
amount of protein that was bound by the antibody; the same calculation applied to the 
IgG sample is subtracted from this first value to correct for unspecific binding. This 
method, even if less direct, could be more precise since it does not suffer from the 
variability of the washing procedure. 
 To compare the co-IP efficiency obtained with the two baits (CAML and WRB), 
the co-IP efficiencies were further normalized to the IP efficiency of the protein used as 
bait. 
 
3.3.2 SDS-PAGE 
 
Polyacrylamide gel electrophoresis (PAGE), is a technique widely used for the 
separation of proteins. In the absence of sodium dodecyl sulfate (SDS) proteins are 
separated according to their electrophoretic mobility which is related to the proteins’ 
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higher order structural organization, the presence of post-translational modifications, 
overall surface charge and molecular weight. Although the analysis of these factors may 
be important for some applications, often one is interested in separating the proteins 
based solely on their molecular weight. For this, one can use SDS-PAGE. 
In this work, protein from cell lysates prepared as described in Section 3.2.3.1 or 
from co-IP reactions prepared as described in Section 3.4.1 were separated in 
polyacrylamide gels (Stacking gel: 4 % [w/v] Acrylamide; 0.125 M Tris-HCl pH6.8; 0.1 % 
[w/v] SDS; 0.13 % [v/v] Temed; 0.065 % [w/v] APS; Resolving gel: 12.5% [w/v] 
Acrylamide; 0.75 M Tris-HCl pH 8.6; 0.1 % [w/v] SDS; 0.06 % [v/v] Temed; 0.03 % [w/v] 
APS) emerged in a glycine buffer (200 mM glycine; 25 mM Tris) with 0.1% SDS under 
constant voltage (120V) before being used for western blot. 
 
3.3.3 Western-blot 
 
After being separated by SDS-PAGE, proteins can be transferred onto an 
immobilizing membrane.  
 In this work, proteins separated by SDS-PAGE were transferred into 
nitrocellulose membranes in the presence of a tris-glycine buffer solution (200 mM 
glycine; 25 mM tris; 20 % [v/v] methanol) by the application of a constant electric current 
for a determined amount of time, either 1 A for 3 hours or 0.16 A overnight. 
 The membranes were then blocked with blocking buffer (20 mM tris; 150 mM 
NaCl;  5 % [w/v] skim milk; 0.1 % [v/v] tween-20) and incubated with the antibodies 
listed in Table 3.2 using the described dilutions, followed by incubation with the 
respective secondary antibodies conjugated with fluorescent fluorophores. The 
membranes were then scanned with the Odyssey CLx Infrared Imaging System (LI-COR) 
and the fluorescence signal from the bands was quantified using Image Studio software 
(LI-COR). 
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Table	3.2	-	Antibodies	used	in	this	work	for	westernblot.	
Type Antibody Description 
Iº a-TUB Monoclonal antibody raised in mouse against a-tubulin; 
clone B-5-1-2 (Sigma) 
Iº a-WRB Affinity purified, MBP depleted, polyclonal antibody 
raised in rabbit against WRBcc (Synaptic Systems) 
Iº a-CAML Polyclonal antibody raised in rabbit against CAML (gift 
from Richard Bram) 
Iº a-GFP Polyclonal antibody raised in rabbit against GFP (MBL) 
IIº a-mouse IR680 Secondary antibody raised in goat against mouse IgG; 
conjugated with IRDye 680 (Li-COR Biosciences) 
IIº a-rabbit IR800 Secondary antibody raised in goat against rabbit IgG; 
conjugated with IRDye 800 (Li-COR Biosciences) 
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4 
RESULTS 
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4.1 The stability of the mRNA of the two subunits 
 
Previous work has shown a strong destabilization of WRB mRNA upon CAML 
silencing (Colombo et al. 2016). This led to the formulation of the hypothesis that the 
transcripts of WRB and CAML could physically interact in such a way that the 
elimination of CAML mRNA by RNA interference could promote the concomitant 
degradation of WRB. The veracity of this hypothesis implied that, also in normal 
conditions, without undergoing silencing treatments, the two transcripts would show 
parallel degradation rates. 
To test this hypothesis, we treated cells with the transcription inhibitor DRB, and 
determined the time course of WRB and CAML diminution by qPCR. As shown in Fig. 
4.1, the two transcripts have very different decay rates: CAML mRNA decayed with a half-
life of 4h, while WRB mRNA was quite stable, with an estimated half-life of ~20h (beyond 
the timescale of the experiment). 
This result indicates that WRB mRNA stability does not depend on the presence 
of CAML transcript, and suggests instead that CAML protein, which is depleted in siRNA 
experiments (Colombo et al. 2016), is required for the stabilization effect. 
Fig. 4.4 – WRB transcript is more stable than CAML mRNA. HeLa cells were treated with DRB for the 
indicated times. The RNA extracted from cell lysates of each time point was subjected to retrotranscription 
and qPCR probing for the transcripts of WRB, CAML and GAPDH. Fold difference, determined using time 
0 as experimental calibrator is shown in the graph as mean ± S.D. of triplicate measures of two independent 
experiments.	
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4.2 The effect of CAML silencing on the expression of a WRB 
transcript that lacks the endogenous UTRs 
 
As already elucidated in the introduction, the UTRs are strongly involved in the 
post-transcriptional mechanisms that regulate, among other things, mRNA translation 
and stability. To investigate if the UTRs of the WRB mRNA could play a part in the 
destabilization of WRB transcript caused by CAML silencing, a WRB tagged construct 
(WRB-HA), lacking the endogenous UTRs was expressed in CAML silenced cells 
(siCAML).  
Analysis of the protein levels, in comparison to a control (cells treated with 
scramble siRNA - siSCR), showed that, while the endogenous WRB is depleted upon 
CAML silencing (as seen before), the same is not true for WRB-HA (Fig. 4.2). The 
expression of WRB-HA was not affected by the silencing of CAML. This result suggests 
that the WRB mRNA UTRs could indeed be playing a role in the observed effect of CAML 
silencing. 
Fig. 4.2 – CAML silencing reduces the levels of endogenous WRB but not those of WRB-HA expressed 
from a transcript lacking the endogenous UTRs. HeLa cells were treated with either a scramble (siSCR) or a 
CAML targeted siRNA (siCAML) for 48h and then transfected with the pRK5rs-WRB-HA plasmid that codes 
for WRB fused with a HA tag, and lacks WRB endogenous UTRs, together with a GFP-encoding plasmid, as 
reporter for transfection efficiency. (A) 24h after transfection cells were lysed and equal aliquots of lysate were 
analysed on SDS-PAGE followed by western blotting with the indicated antibodies. The HA tagged form of 
WRB runs slower on SDS-PAGE and is indicated with a white arrowhead while the endogenous form of WRB, 
which runs faster, is indicated with a black arrowhead. The hashtag (#) indicates an unidentified band 
produced by the expression of the pRK5rs-WRB-HA plasmid. (B) The intensities of the bands corresponding 
to each protein were quantified and Tubulin and GFP were used as normalizers for endogenous and 
transfected proteins, respectively. The fold-change with respect to control cells is shown in the graph as mean 
± S.D. of three independent experiments each analysed in duplicate; * indicates p<0.05 for differences between 
silenced and control cells for each protein analysed by multiple t-test, with Holm-Sidak method for multiple 
comparison correction, after logarithmic transformation of the normalized band intensities.	
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4.3 The WRB 3’ UTR 
 
The GenBank annotation for WRB (Gene ID: 7485), predicts six different mRNA 
isoforms resulting from alternative splicing or promoters; isoform 1 is the one that codes 
for full length WRB. The isoforms vary at the 5’ end, with two of the isoforms potentially 
coding for truncated forms of WRB, that lack the N-terminal, membrane-associating 
portion. The relevance of these isoforms is yet to be investigated.  
As stated in the introduction, the 3’UTR of a mRNA is known to be a regulatory 
hub, where most binding sites for RBPs that regulate mRNA stability are present. 
Considering this, the sequence of the 3’UTR of WRB mRNA was analyzed in greater 
detail using 3’ RACE to look for potential variations to the annotated sequence. This 
technique uses a oligodT containing backward primer, and a gene specific forward 
primer, so as to obtain amplicons of all polyadenylated 3’UTRs of the investigated 
transcript (see Methods). 
Surprisingly, this analysis revealed a heterogeneous population of polyadenylated 
3’UTRs (Fig. 4.3-B). The main 3’ RACE product populations (bands a, b and c) were 
cloned into a pCRII-TOPO cloning vector and some of the resulting colonies were 
sequenced. Sequence alignment of the 3’RACE products with the annotated WRB 
transcript isoform 1 (and with all other isoforms – not shown) revealed that all sequenced 
transcripts aligned almost perfectly at the 5’ end of the annotated 3’ UTR, but some were 
shorter in length (Fig. 4.3-C; D).  
It must be noted that some transcripts originating from molecular cloning of 
different 3’RACE product populations are identical. This is probably due to inefficient 
electrophoretic separation that resulted in cross-contamination of the different 
populations. 
Furthermore, a bioinformatic analysis of the full length WRB 3’UTR revealed the 
presence of three putative ARE motifs. These motifs are known to be important for the 
regulation of the stability of mRNA. The position of the three AREs is represented in pink 
on the cartoon and in the sequence (Fig. 4.3-D). 
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Fig. 4.3 – WRB transcript has an upstream ATG and is present in multiple isoforms that vary in 3’UTR 
length. (A) The deposited sequence for WRB 5’UTR (NM_004627.5); the presence of an upstream ATG is 
highlighted in yellow and in red is highlighted the in frame STOP codon. The main ORF ATG is represented 
in capital letters. (B) RNA extracted from HeLa cell lysates was retrotranscribed using either random 
primers or a 3’RACE adaptor to generate templates A and B, respectively. The two templates were then 
submitted to PCR amplification with specific primer pairs: primers 3, 4, 8 and 9, indicated in panel B. The 
different amplicons (a, b and c) obtained from Template B were isolated and cloned into a pCRII-TOPO 
cloning vector. Two constructs resulting from the cloning of each amplicon were sequenced. (C) Sequences 
from each of the produced constructs were aligned with the deposited sequence for WRB transcript, to 
which was added the 3’RACE adaptor sequence (schematized at the bottom of the panel). The matching 
regions of the sequence are shown in full red while the missing portions are represented by dotted lines. In 
the scheme are also represented (in pink) the four AUUUA pentamers within the 3'UTR, which are 
hallmarks of AREs. (D) The deposited sequence of WRB 3’UTR. Arrowheads indicate the positions of 
premature termination, with resulting truncated UTRs, identified by 3’RACE. The ARE pentamers 
represented in (C) are highlighted in pink. 
 
	 68	
4.4 The role of the UTRs in the regulation of WRB mRNA 
expression and on its CAML-sensitive stability 
 
To investigate the importance of the WRB UTRs on its expression and on the 
CAML-sensitive stability, a dual-luciferase reporter system was used, with luciferase 
constructs carrying both WRB 5’ and 3’ UTRs. 
Regarding the 5’UTR, bioinformatic analysis revealed that WRB has an upstream 
ATG of unknown consequence (Fig. 4.3-A). To analyse the importance of this upstream 
ATG, a set of luciferase constructs with this ATG mutated were designed. As described in 
the introduction, upstream initiation codons followed by an in frame stop codon may 
decrease the efficiency of translation of the main ORF. The upstream ATG of WRB 
transcript partially conforms to the Kozak consensus sequence, and could thus be used 
for translation. This would result in interruption of the scanning process, and consequent 
failure of the small ribosomal subunit-containing initiation complex to reach the 
subsequent AUG at the start of the main ORF of the transcript. 
The 3’UTR sequence used was that annotated for isoform 1 of the WRB transcript, 
corresponding to our longest 3’RACE product. 
First, the effect of each UTR, alone or combined, on the expression of luciferase 
was studied (Fig 4.4-A). Constructs carrying the 5’UTR were significantly less expressed 
(40% reduction) than the control. However, when the upstream ATG was mutated, the 
expression was restored to control levels. The 3’UTR, either alone or in combination with 
the 5’UTR did not have any effect on luciferase. 
Next, the sensitivity of the different UTRs to CAML silencing was tested by 
expressing the various luciferase constructs in CAML silenced cells. To begin, it must be 
stated that treatment with different siRNAs influenced the expression of the luciferase 
backbone, reducing its expression by ~0.5 fold (see figure legend). The causes for this 
effect are not clear. Because of this, the analysis was performed on differences in fold-
variation of luciferase expression with respect to the backbone control, for CAML 
silenced or control cells. 
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Fig. 4.5 -  The UTRs regulate the expression of WRB and the 3’UTR is responsible for the CAML-
sensitive stability. (A) Luciferase constructs driven by the TK promoter and fused with WRB’s UTRs were 
transiently transfected in HeLa cells together with a Renilla control plasmid. **** indicates statistical 
significant differences between the indicated groups, analysed by unmatched analysis of variance and Tukey 
post-hoc test, F (5,12) = 149.9, p<0.0001. (B) The same Luciferase constructs were transiently transfected 
together with a Renilla control plasmid in HeLa cells previously treated with either a scramble (siSCR) or a 
CAML-targeted (siCAML) siRNA for 48h. siRNA treatment (independently of the siRNA target) had an 
off-target effect on the luciferase backbone, causing a 59% reduction in its activity with respect to scramble. 
Considering this, the analysis of the data was performed as fold-variation in Luciferase activity of each 
construct with respect to the backbone for CAML silenced or control samples. * and ** indicates statistically 
significant differences, in the fold-variation, with respect to the backbone, between the indicated groups, 
analysed by unpaired Student’s t-test (p<0.05 and p<0.01 respectively). For both panels, the Luciferase 
activity, determined 24h after transfection, was measured as a function of luciferase luminescence signal 
normalized to Renilla luminescence signal. Values are expressed as mean ± S.D. of fold-variation of three 
independent experiments, each performed in duplicate. 
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As shown in Fig. 4.4-B, the expression of 5’UTR constructs did not change 
significantly in response to CAML silencing, irrespectively of the presence or not of the 
upstream ATG. By contrast, constructs carrying the WRB 3’UTR were significantly less 
expressed with respect to the backbone in CAML silenced cells (~0.5 fold). This reduced 
expression was observed in all the constructs containing the 3’UTR, regardless of whether 
it was alone or in combination with the wt or mutated 5’UTR. 
 As indicated above, the WRB 3’UTR, here shown to be responsible for the 
sensitivity of WRB to the silencing of CAML, has three putative ARE motifs. ARE motifs 
have been proposed to be very important for the regulation of mRNA stability. Thus, 
considering the presence of these putative AREs (Fig 4.3-C; D), a new luciferase construct 
containing a portion of the 3’UTR that excluded the AREs (Fig. 4.5-A) was designed. As 
shown in Fig. 4.5-B, expression of this construct was equally sensitive to CAML silencing 
as the one containing the full-length 3’UTR. Thus, the CAML-sensitive stability of WRB 
mRNA is not mediated by the ARE sites. 
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Fig. 4.6 – The stabilization of the WRB mRNA by CAML is not ARE-mediated. (A) Schematic 
representation of the AREless region of the WRB transcript cloned into pTKpGL4.11 (see Section 3.2.1.10 
for details). (B) Luciferase constructs, with either full length or an AREless portion of WRB 3’UTR, were 
transiently transfected together with a Renilla control plasmid in HeLa cells previously treated with either a 
scramble (siSCR) or a CAML-targeted siRNA (siCAML) for 48h. Luciferase activity, determined 24h after 
transfection, was measured as a function of Luciferase to Renilla luminescence signals. Values are expressed 
as mean ± S.D. of fold-variation in Luciferase activity with respect to the Luciferase backbone of one 
experiment performed in duplicate. 
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4.5 Characterization of the WRB-CAML interaction 
 
In yeast, Get1 and 2 form a complex, the two subunits are expressed in 
approximate 1:1 ratio, and deletion of one subunit causes depletion of the other one 
(Mariappan et al. 2011). This result is consistent with the idea that the two subunits form 
a 1:1 complex, and that each subunit is required for its partner’s stability (see 
Introduction). In mammals, however, the situation appears to be more complex. On the 
one hand, WRB and CAML form a complex (Yamamoto and Sakisaka 2012; Colombo et 
al. 2016), and the overexpressed proteins are unstable in yeast unless expressed together 
(Vilardi et al. 2014), suggesting that the relationship between CAML and WRB is similar 
to the one between Get1 and 2. On the other hand, however, a study from my laboratory 
(Colombo et al. 2016), based on quantitative immunoblotting reported that in 
mammalian cells CAML is present in ~5-fold excess over WRB. This finding fits well with 
the multiple reported functions of CAML (Shing et al. 2017), but is difficult to reconcile 
with the effect of WRB depletion on CAML expression levels. 
To reconcile these previous contradictory findings, I considered the possibility 
that, in mammals, WRB and CAML might form a super-complex, in which CAML would 
be in molar excess over WRB. The previous study (Colombo et al. 2016) had 
demonstrated that WRB is quantitatively associated with CAML, but the reverse, whether 
all CAML is associated with WRB, had not been tested. 
To investigate the stoichiometry of the complex, I carried out co-
immunoprecipitation experiments with anti-WRB and anti-CAML antibodies. If all the 
excess CAML were in complex with WRB, one would expect it to co-precipitate with 
WRB with the same efficiency as the reverse precipitation (WRB with CAML). 
Cell lysates were prepared with a mild detergent (DBC) that preserves the WRB-
CAML complex (Colombo et al. 2016). As shown in Fig. 4.6, using WRB as bait, also a 
fraction of CAML was co-precipitated (Fig. 4.6-A; B; D). In parallel, an antibody raised 
against CAML could immunoprecipitate native CAML itself while pulling down together 
a considerable fraction of WRB. 
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Fig. 4.7 – Co-immunoprecipitation of the WRB/CAML complex reveals the presence of a WRB-free 
population of CAML. (A) HeLa cells were mechanically lysed in a DBC containing buffer. The post-nuclear 
supernatant (PNS) obtained was used for co-immunoprecipitation with either anti-WRB or anti-CAML 
antibodies, rabbit IgG was used as control. Input, bound and unbound fractions were then analyzed on SDS-
PAGE followed by western blotting with the indicated antibodies. (B) The bands corresponding to each 
protein present in the Bound fraction were quantified and the percentage of IP efficiency, quantified using 
“Method 1” (see Section 3.3.1). (D) The bands corresponding to each protein present in the Unbound 
fraction were quantified and the percentage of IP efficiency, quantified using “Method 2” (see Section 3.3.1). 
Percentage of IP efficiency is shown in the graph as mean ± half-range of two independent experiments. (C 
and E) The means of the percentage of immunoprecipitated protein obtained from each method were 
normalized to the percentage of precipitated bait. 
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The interpretation of the results was not straightforward, because, while the anti-
CAML antibody was fairly efficient in immunoprecipitating its cognate antigen, the anti-
WRB antibody was much less proficient in immunoprecipitation (Fig. 4.6-A; B). 
As stated in the Methods section, two different procedures were used to quantify 
the IP and co-IP efficiency. The first one (Fig. 4.6-B) uses the amount of protein found in 
the “Bound” fraction, while the second one (Fig. 4.6-D) uses the amount of protein found 
in the “Unbound” fraction. Although some differences in the efficiency of the various IPs 
were observed for the different methods, the overall result was rather similar. To better 
appreciate the result and considering the variability in antibody efficiency, the co-IP 
efficiency of each prey was normalized to the IP efficiency of the respective bait (Fig. 4.6-
C; E). In the hypothesis that all WRB interacts with all CAML, the relative efficiency of 
co-IP should be similar, independently on the bait being used. However, that was not 
observed. The relative amount of CAML that was pulled down with WRB was lower than 
the relative amount of WRB that was pulled down with CAML. This result confirms the 
molar excess of CAML over WRB reported by Colombo et al. (2016) and furthermore 
indicates the existence of a population of CAML that is not bound to WRB. 
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4.6 The effect of WRB silencing on CAML transcript stability 
 
Although the silencing of CAML was seen to provoke a great destabilization of the 
WRB transcript, the reverse situation showed that CAML transcript levels were only 
slightly reduced upon WRB silencing (Colombo et al. 2016). To further investigate the 
effect of WRB silencing on CAML at both protein and transcript levels, I investigated 
whether the stability of the CAML transcript is affected by WRB depletion, as occurs in 
the reverse case. The results are shown in Fig. 4.7. 
 
Fig. 4.8 – The silencing of WRB depletes CAML protein but does not affect either the amount or the 
stability of the transcript. HeLa cells were treated with either a control scramble (siSCR) or a WRB targeted 
siRNA (siWRB) for 68h. (A) Cells were lysed and equal aliquots of lysate were analysed by SDS-PAGE 
followed by western blotting with the indicated antibodies. (B) The band intensity of each protein was 
quantified and Tubulin was used as endogenous normalizer. The fold-variation of WRB silenced cells with 
respect to control is shown in the graph as mean ± S.D of two independent experiments analysed in 
duplicate. (C) RNA extracted from WRB silenced and control cells was subjected to retrotranscription and 
qPCR probing for WRB, CAML and GAPDH mRNA. Fold difference was determined with siSCR as 
experimental calibrator for each probe. The result is shown in the graph as mean ± S.D of triplicate measures 
of two independent experiments. (D) After silencing, cells were treated with DRB (60µM) for the indicated 
times. The RNA extracted from cell lysates of each time point was subjected to retrotranscription and qPCR 
probing for the transcripts of CAML and GAPDH. Fold-variation, determined using time 0 (cells not 
exposed to DRB) as experimental calibrator, is shown in the graph as mean ± S.D. of triplicate measures of 
two independent experiments. 
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Confirming the results of Colombo et al. (2016), the silencing of WRB, greatly 
reduced the levels of CAML protein (Fig. 4.7-A; B) while not having any effect of the 
transcript levels (Fig. 4.7-C). To understand if the silencing of WRB had any effect on the 
stability of CAML mRNA, the levels of CAML transcript were analysed over time after 
inhibition of transcription as described for the experiments of Fig. 4.1 (Fig. 4.7-D). The 
results show that there is no significant effect of WRB silencing on the overall stability of 
CAML transcript. In control cells (siSCR), the half-life of CAML transcript was ~6h, close 
to that found in control cells (Fig. 4.1). This value remained unchanged in cells silenced 
for WRB. This result indicates that the depletion of CAML protein upon WRB silencing 
is not due to the destabilization of its transcript, as is to be the case for the reverse 
situation.  
The reason for the depletion of CAML protein upon WRB silencing remained 
elusive. It was hypothesised that it could be either due to a loss of CAML protein stability 
or to a potential interaction of WRB with some translational regulation factor present in 
CAML UTRs. To investigate this, a CAML tagged construct (FLAGCAML), that lacked 
the endogenous CAML UTRs, was expressed in WRB silenced cells. The results show that, 
although not statistically significant, there was a 40% reduction in the expression of 
FLAGCAML when WRB was silenced (Fig. 4.8), suggesting that WRB depletion interferes 
with CAML protein stability. 
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Fig. 4.9 – The effect of WRB silencing on CAML is independent of CALM’s UTRs. HeLa cells were treated 
with either a control scramble (siSCR) or a WRB targeted siRNA (siWRB) for 72h, after which they were 
transfected with the pCLX31.1-FLAGhCAML plasmid, which codes for a FLAG tagged form of CAML and 
lacks the endogenous UTRs, together with a plasmid encoding GFP, as reporter for transfection efficiency. 
(A) After 24h of transfection cells were lysed and equal aliquots of lysate were analysed on SDS-PAGE 
followed by western blotting with the indicated antibodies. FLAG tagged CAML which migrates more 
slowly on SDS-PAGE is indicated with a white arrowhead while endogenous CAML is indicated with a black 
arrowhead. (B) The intensity of the blotted bands was quantified; Tubulin and GFP were used for 
normalization of endogenous and transfected proteins, respectively. The fold-change with respect to siSCR 
treated cells is shown in the graph as mean ± S.D. of three independent experiments, each analysed in 
duplicate; * indicates p<0.05 for differences between silenced and control cells for each indicated protein 
analysed by multiple t-test, with Holm-Sidak method for multiple comparison correction, after logarithmic 
transformation of normalized band intensities. FLAGCAML levels are reduced by WRB silencing, although 
the difference did not reach statistical significance. 
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5 
DISCUSSION 
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In this thesis, I have investigated novel mechanisms by which two subunits of a 
protein complex, the TRC40 receptor, influence each other's expression in mammalian 
cells. My results reveal previously undescribed modalities of subunit co-regulation, which 
may likely be relevant also for other complexes, including oligomeric receptors and ion 
channels. I discuss in turn WRB regulation by CAML, and, viceversa, CAML regulation 
by WRB. 
 
5.1 How CAML depletion affects WRB levels 
 
5.1.1 WRB transcript stabilization is mediated by CAML protein and 
not CAML transcript 
 
My research had as starting point the unexpected observation by Colombo et al. 
(2016) that CAML depletion causes instability of the WRB transcript. Since the siRNA 
technique causes the degradation of the target mRNA with consequent depletion of the 
protein product, my first question was whether the stabilization of the WRB transcript by 
CAML was due to the CAML transcript or to the CAML protein. Indeed, a recent study 
demonstrated that the mRNAs encoding two subunits of a heteromeric K+-channel 
expressed in cardiomyocytes are physically associated, and each one influences the 
stability of the other one (Liu et al. 2016). We reasoned, that if this were the case also for 
the WRB-CAML pair, the two transcripts should show parallel degradation kinetics, 
revealed after a block of transcription by DRB. We found instead that the two transcripts 
had distinctly different stabilities, such that the one encoding WRB were hardly affected 
by an ~80% reduction in CAML transcript at 8 h of treatment with DRB. This result 
indicates that the destabilizing effect of CAML silencing on WRB transcript is mediated 
by CAML protein. 
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5.1.2 WRB transcript stabilization by CAML is mediated by the 3' UTR. 
 
As described in the Introduction, a frequently observed phenomenon in the 
biogenesis of protein oligomers is the association of one subunit with the nascent 
polypeptide chain of other subunits of the complex (Duncan and Mata 2011). This 
interaction allows for efficient assembly of the complex, but could also affect the stability 
of the captured mRNA. On the other hand, it is well known that the UTRs, especially the 
3'UTR, play a key role in determining mRNA stability. To investigate whether CAML 
interacts with WRB nascent chains or whether its effect is mediated by interactions of the 
UTRs, I expressed a tagged WRB construct that is translated from a transcript lacking the 
UTRs of the endogenous WRB transcript. I found that the levels of transfected tagged 
WRB were not affected by CAML silencing, strongly suggesting that the WRB UTRs 
underlie instability of the transcript in the absence of CAML. This conclusion was 
confirmed by my experiments with luciferase constructs carried out in CAML-depleted 
or control cells. Indeed, the 3'UTR reduced luciferase expression when CAML was 
depleted, while it had no effect in control cells.  Furthermore, the 3' UTR was not only 
necessary, but also sufficient for this effect. Indeed, while the 5' UTR also reduced 
luciferase expression, this effect, which was due to the upstream AUG, was insensitive to 
the presence or absence of CAML.  
 
5.1.3 AU- rich elements (AREs). 
 
The above results confirmed that the coding sequence of the WRB transcript is 
not involved in the CAML effect and demonstrated that the 3'UTR is the region of the 
mRNA that underlies the instability of the transcript in the absence of CAML. My next 
step was to identify the region within the 3'UTR responsible for the instability and for the 
CAML-dependent stabilization. Upon analysis of the 3'UTR, I noticed three possible 
Class I ARE motifs; these are defined as containing 1-3 interspersed copies of the 
pentamer AUUUA surrounded by U-rich regions (Wu and Brewer 2012). Analysis of the 
WRB mRNA 3'UTR using the AREsite2 software, identified three potential AREs, two 
between position 655 and 703, at 247 nucleotides from the polyA, and one upstream 
sequence at position 63-68. I considered these three sequences as candidate mediators of 
the observed phenomenon. Here I give a brief summary of the features of these key 
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regulatory elements. 
As briefly mentioned in the introduction (Section 1.4), ARE motifs are 3’UTR 
elements that are the target of several RBPs, composing a complex regulatory network 
that affects mRNA localisation, translation and stability (review: Wu and Brewer 2012). 
The complexity of the ARE-mediated regulation is demonstrated by several reports 
indicating that multiple proteins can bind to these motifs, competing between each other 
to regulate stability and/or translation and also the interaction of miRNAs with the target 
mRNAs. 
RBPs bind to ARE motifs through diverse domains including RNA-recognition 
motifs (RRM), CCCH tandem zinc fingers and K-homology domains (KH). Moreover, a 
single protein can have multiple motifs, which provide them with the ability to 
simultaneously bind to multiple targets or multiple sites in the same target. To date, over 
twenty ARE-binding proteins (ARE-BP) have been identified, some of them with 
potentially redundant functions and other with contradictory reports on how they affect 
the target mRNA (Shen and Malter 2015). Some of the best characterized ARE-BPs are 
AUF1, TTP, TIA-1, TIAR, KSRP and HuR. These ARE-BPs are often catalogued based 
on their most common effect on target mRNA: TTP, KSRP and AUF1 (in an isoform 
dependent way) are usually reported as promoting mRNA degradation; HuR and AUF1 
(again, depending on the isoform) are often referred to as mRNA stabilizers; TIA-1 and 
TIAR are said to be translational repressors (Khabar 2017). However, this classification is 
not always straightforward, and the same ARE-BP can - depending on target mRNA, type 
of stimulus, or environmental cues - present opposite behaviours regarding target 
modulation. These contrasting functions for singular ARE-BPs may be due to the fact that 
ARE-BPs may present a high level of crosstalk with another class of mRNA regulatory 
factors, miRNAs (Ho and Marsden 2014; Plass et al. 2017). This crosstalk is thought to be 
responsible for the complex, often contradictory, regulation of target mRNA fate by 
AREs. For instance, it has been suggested that a single ARE-BP can either compete with 
miRNAs for binding (Simone and Keene 2013) or cooperate with miRNAs to stabilize or 
degrade a target mRNA (Sharma et al. 2013). 
Interestingly, this ARE-BP-mediated modulation of the destiny of target mRNAs 
is regulated also by ARE-BP post-translational modifications. The ability of these proteins 
to interact with target mRNAs and with each other has been seen to be strongly affected 
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by ARE-BP phosphorylation by MAPK and PI3K/AKT signalling cascades, allowing the 
ARE-BP to quickly modulate the expression of several early response genes, such as 
cytokines, lymphokines and proto-oncogenes (Winzen et al. 2004; Palanisamy et al. 2012; 
Shen and Malter 2015).  
 
5.1.4 The WRB transcript AREs are not involved in mediating CAML-
sensitive instability. 
 
Given the widespread effect of AREs on mRNA metabolism, I investigated their 
potential role in mediating the effect of CAML on WRB transcript stability. I therefore 
produced a luciferase construct, in which the 3'UTR was truncated at position 438, with 
the consequent deletion of the downstream AREs; in addition, the first 68 nucleotides of 
the 3'UTR were deleted, with removal of the upstream ARE. Unexpectedly, I found that 
the resulting “mini”-3' UTR was as effective as the full-length sequence in reducing 
luciferase expression in the absence, but not in the presence, of CAML. Although this 
result did not meet my expectations, it restricts the CAML-sensitive regulatory portion of 
the 3'UTR to 370 nucleotides (position 69 - 439 of the 3'UTR). My future work will be 
directed at further restricting the active portion to identify the responsible sequence. 
 
5.1.5 What is the mechanism through which CAML stabilizes the WRB 
transcript? 
 
As illustrated in Fig. 5.1, left panel, I favour a model, in which CAML would 
directly or indirectly associate with the 3' UTR of the WRB transcript. This association 
would have three beneficial effects: (i) it would keep the WRB transcript close to the ER 
membrane; this would allow the hydrophobic stretches at the N-terminus (the future 
TMDs) to have easier access to the Sec61 translocon for subsequent insertion into the ER 
bilayer. In the classical model of membrane protein insertion into the ER, it is SRP, via 
the SRP receptor, that brings the ribosome-mRNA-nascent polypeptide complex to the 
ER membrane for subsequent delivery to Sec61 (Blobel and Dobberstein 1975; Blobel 
2000). However, SRP recognition may not always be 100% efficient, and the occurrence 
of translation of a membrane protein in the cytosol could be very harmful to the cell. 
Thus, it is not surprising that ribosome-independent anchorage to the ER of mRNAs 
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coding for membrane proteins has been observed (Cui et al. 2015; Chen et al. 2011). The 
possibility of direct delivery of nascent chains to the translocon, bypassing the SRP step, 
has also been reported (Potter and Nicchitta 2002); (ii) it would guarantee translation of 
WRB to occur in proximity to its CAML partner, thus facilitating assembly (see 
Introduction); (iii) by restricting WRB mRNA to the ER compartment, it would protect 
it from access to the RNA degradation machinery of the cell, resulting in the observed 
stabilization.  
 CAML does not have any known RNA binding motifs, thus it is difficult to 
envisage, although it is fully possible, that it directly binds the 3' UTR of the WRB 
transcript. However, its interaction with WRB mRNA's 3'UTR could be mediated by 
another protein, or even by a miRNA (see Fig. 5.1).  Indeed, the utilization of online 
software miRWalk2.0 to identify miRNA recognition sequences in WRB mRNA's 3' UTR 
identified one sequence as potential target for miRNA 24-1.  
 Admittedly, at the present stage of my research, I cannot exclude that CAML's 
effect on WRB mRNA's stability is indirect, mediated by a cascade of events related to the 
many reported functions of CAML (Shing et al. 2017). CAML could alter the expression 
levels of a stabilizing or destabilizing factor (protein or miRNA). My current research is 
directed at demonstrating (or excluding) the existence of a complex between CAML and 
WRB mRNA. 
 
5.1.6 WRB mRNA's CAML-sensitive stability: a failsafe mechanism to 
avoid useless translation of a "lonely" subunit. 
 
As described in the Introduction, quality control systems in the cell ensure that 
oligomer subunits, if produced in excess over their partners, are rapidly degraded, and 
this phenomenon is generally thought to underlie the reduction of the levels of all 
complex subunits, when one of them is depleted by RNA interference. My results show 
that, in addition to this quality control mechanism, regulation of the transcript levels may 
also be important. It should be noted that, while my results indicate that a free pool of 
CAML exists in the ER, the reverse is not true: indeed, previous results from my lab 
(Colombo et al. 2016) demonstrated that WRB is quantitatively associated with CAML. 
 Whatever the mechanism by which CAML stabilizes the WRB transcript, the final 
result will be that WRB is not produced in the absence of CAML. Such a regulation, 
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operating at the level of the transcript, is a cost-effective way of limiting the presence of a 
"lonely" subunit. If no CAML is around, why should the cell spend the energy to produce 
WRB and then degrade it? To be noted, also degradation by the ubiquitin-proteasome 
system is an energy-consuming process. Of course, in real life, CAML levels may vary, but 
are not expected to fall to nearly zero, as in siRNA experiments. Nevertheless, the 
physiological implications of my results are clear: WRB production is expected to be 
regulated by the availability of CAML, and could thus be modulated by variations in the 
levels of its partner. 
 
5.2 How WRB depletion affects CAML levels 
 
My investigation of the effects of WRB silencing on CAML transcript levels 
yielded results quite different from those obtained for the reverse situation. Indeed, in 
agreement with a recent study on conditional knockout mice (Rivera-Monroy et al. 2016), 
CAML transcript levels and its stability were unaffected by WRB depletion. It must be 
stated that the results on the transcript levels were slightly different from those obtained 
by Colombo et al. (2016), who did observe a 20-30% reduction in CAML transcript 
following WRB silencing. While at present I do not know the reason for this discrepancy, 
in both my hands and in the studies of Colombo et al. and of Rivera-Monroy et al, CAML 
protein levels did not go in parallel with those of CAML transcript: in my hands, CAML 
transcript was unaltered, and CAML protein was depleted to the same extent as WRB; in 
the study of Colombo et al., a ~25% reduction in CAML transcript levels was 
accompanied by depletion of 90% of CAML. These results indicate that, in the absence of 
WRB, CAML protein is not expressed in cells, and strongly suggests that CAML stability 
requires the presence of WRB protein. This conclusion was strengthened by the 
observation that expression of a tagged form of CAML, expressed from a cDNA lacking 
the UTRs, was reduced upon WRB silencing, differently from the result obtained in the 
specular experiment (tagged WRB expression from a cDNA lacking the UTRs was not 
affected by CAML silencing). 
 The dependency of CAML on WRB protein could be easily understood if  
CAML were quantitatively included in a WRB-containing complex. That this is not the 
case was already suggested by the work of Colombo et al. (2016), and directly shown here 
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by co-immunoprecipitation experiments.  When normalized to the efficiency of 
immunoprecipitation of the antibodies, 50-70% of WRB co-precipitated with CAML, 
while only 10-30% of CAML co-precipitated with WRB from the same lysate. Thus, it 
appears that at least 50% of the CAML molecules exist free of WRB. 
 So, how can the destabilization of CAML in the absence of WRB be explained, 
given the large pool of free CAML molecules that exist without being associated with 
WRB?  Clearly the effect of WRB on CAML cannot be mediated by a stoichiometric 
mechanism, and must be catalytic. I suggest that this catalytic mechanism could consist 
WRB assisting CAML insertion into the ER membrane. CAML's TMDs are close to its C-
terminus; they might, therefore, be inefficiently recognized by SRP. Indeed, in yeast, it 
has been shown that recognition by SRP is optimal if the position of the hydrophobic 
sequence in the nascent chain is not too far removed from the N-terminus (Aviram et al. 
2016). Although CAML is not a TA protein, the vicinity of its TMDs to the C-terminus 
might permit it to interact with TRC40; in this case, the TRC40 receptor (WRB/CAML) 
would be involved in its insertion into the ER membrane. In other words, CAML would 
use itself to integrate into the bilayer. This situation would not be unusual: for instance, 
also the α subunit of Sec61 requires a pre-existing Sec61 translocon to integrate into the 
ER membrane (Knight and High 1998). In the absence of integration into the ER 
membrane, CAML would be recognized by the UPS and degraded. Our model for the role 
of WRB in CAML biogenesis is depicted in Fig. 5.1 (right). 
5.3 Conclusions 
 
The research for this thesis has uncovered novel, and unexpected modes of 
regulation of the expression of oligomer subunit. Indeed, I show that, beyond the 
important concept of quality control, meaning with this the degradation of unassembled 
oligomer subunits, mRNA stability of one subunit can be affected by depletion of another 
one, and that protein stability may be affected also in cases in which a portion of one 
subunit is not incorporated in the oligomer. These novel observations may be relevant for 
other protein complexes, and open a large number of questions, which I summarized in 
the preceding sections of this discussion, and which I hope to address in my future 
research. 
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Fig. 5.1 – Models for the mechanism of reciprocal regulation of the expression of TRC40 receptor 
subunits. Row 1: under normal conditions WRB (red) is quantitatively associated with CAML (green), but, 
in addition, a pool of CAML subunits not associated with WRB is present. Row 2: silencing of CAML (left) 
or of WRB (right), indicated by the crosses, results in depletion of the companion subunit (represented as 
ghosts in light colour). Row 3: left: under normal conditions, WRB mRNA is kept close to the ER membrane 
thanks to the interaction of its 3' UTR with CAML. The possibility of an indirect interaction with CAML is 
indicated by the black triangle (X). WRB nascent polypeptide is generally recognized by SRP (black), but 
could also be directly delivered to the ER membrane, thanks to the CAML-mRNA association. The 
compartmentalization of the WRB transcript protects it from access to nucleases (indicated by the scissors). 
When CAML is absent (black cross) the association of the WRB transcript with the ER membrane is in part 
lost (mediated now only by the SRP-SRP receptor interaction). The free WRB transcript is now accessible 
to the RNA degradation machinery. Right: under control conditions, the C-terminal TMD of CAML is 
recognized by TRC40, and delivered to the ER membrane via interaction with the TRC40 receptor, 
composed of WRB and CAML itself. When WRB is absent, TRC40 cannot deliver its cargo to the ER, and 
CAML, released into the cytosol, is degraded. See text for further explanation.  
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